{"study_id": 38236, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Sulforaphane (SFN) induces ferroptosis in osteosarcoma (OS) and its potential as a therapeutic agent.", "results_summary": "SFN was found to act as a potent ferroptosis inducer in OS, characterized by elevated ROS levels, lipid peroxidation, and GSH depletion, mediated by decreased SLC7A11 levels. In vivo models confirmed SFN's anti-cancer efficacy via ferroptosis.", "population_specificity": "Osteosarcoma cells and nude mice with subcutaneous/intratibial OS models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:08.960943+00:00"}
{"study_id": 38237, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine Sulforaphane's effects on antioxidant signaling, mitochondrial respiration, and ATP production in C2C12 myotubes.", "results_summary": "Sulforaphane increased nuclear localization of Nrf-2 within 4 hours, leading to a 2-fold increase in antioxidant enzymes NQO1 and HO-1 by 24-48 hours, and significantly enhanced mitochondrial respiration and ATP production by 24-48 hours.", "population_specificity": "C2C12 myotubes (in vitro skeletal muscle cell model)", "effective_dosage": "Not specified", "study_duration": "Up to 48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:09.468642+00:00"}
{"study_id": 38238, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the anticancer effects of sulforaphane (SFN) in pancreatic cancer cells (Mia PaCa-2) and evaluate its molecular mechanisms involving the GSK-3\u03b2-related pathway.", "results_summary": "SFN increased phosphorylated GSK3\u03b2 (Ser9) and \u03b2-catenin levels while decreasing NF-\u03baB, cMyc, and BCL-2 expression, promoting apoptosis and inhibiting cell proliferation via the GSK3\u03b2/NF-\u03baB/cMyc pathway.", "population_specificity": "Human pancreatic cancer cell line (Mia PaCa-2).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:11.783091+00:00"}
{"study_id": 38240, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane could alleviate renal fibrosis in mice and elucidate its mechanism of action via mTOR-mediated autophagy regulation.", "results_summary": "Sulforaphane significantly reduced renal fibrosis in UUO mice and differentially regulated autophagy activity\u2014upregulating it in renal fibroblasts while downregulating it in renal tubular epithelial cells\u2014via mTOR pathway modulation.", "population_specificity": "Unilateral ureteral obstruction (UUO) mice and in vitro renal fibroblasts and renal tubular epithelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:12.403693+00:00"}
{"study_id": 38242, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether sulforaphane (SFN) could inhibit TGF-\u03b2-induced fibrosis, myofibroblast differentiation, and inflammation in human Tenon's fibroblasts (HTFs).", "results_summary": "SFN significantly suppressed TGF-\u03b2-induced myofibroblast contraction, reduced fibronectin and \u03b1-SMA production, and lowered inflammatory markers (IL-6, IL-8, CTGF). It also attenuated TGF-\u03b2 signaling pathways (Smad2/3, ERK phosphorylation).", "population_specificity": "Human Tenon's fibroblasts (HTFs) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:14.343334+00:00"}
{"study_id": 38243, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role and mechanism of Sulforaphane in phosgene-induced acute lung injury (P-ALI) and provide a theoretical basis for its clinical prevention and treatment.", "results_summary": "Sulforaphane ameliorated phosgene-induced lung injury by reducing inflammation and oxidative stress, likely through activation of the Nrf2-HO-1/NQO1 signaling pathway. The protective effects were attenuated by the Nrf2 inhibitor ML385.", "population_specificity": "Mice exposed to phosgene gas.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:15.183789+00:00"}
{"study_id": 38244, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanisms by which Sulforaphane (SFN) targets prostate cancer stem cells (PCSCs) and its effects on Wnt/\u03b2-catenin and hedgehog signaling pathways.", "results_summary": "SFN effectively reduced PCSC activity, including tumorsphere formation, CD133-positive cells, and stem cell marker expression, by inhibiting Wnt/\u03b2-catenin and hedgehog pathways. Molecular docking indicated SFN directly targets \u03b2-catenin and Smoothened, enhancing its inhibitory effects on PCSCs.", "population_specificity": "PC-3 prostate cancer cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:16.296899+00:00"}
{"study_id": 38246, "supplement_id": 1591, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and pharmacokinetics of SFX-01, a stabilized form of Sulforaphane, in healthy male participants.", "results_summary": "The study found that SFX-01 was generally safe and well-tolerated, with mild gastrointestinal adverse events. Pharmacokinetic data showed rapid absorption of SFN, but dose-proportionality and accumulation were inconclusive.", "population_specificity": "Healthy male participants", "effective_dosage": "300 mg once daily (46.2 mg SFN), 300 mg twice daily, or 600 mg once daily (92.4 mg SFN)", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:18.466527+00:00"}
{"study_id": 38245, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of sulforaphane on reducing inflammation and metabolic abnormalities in virally suppressed HIV patients.", "results_summary": "Sulforaphane significantly decreased C-reactive protein levels compared to the control group (p = 0.019), suggesting anti-inflammatory effects. The study did not report on changes in lipid levels or fat mass in this human trial.", "population_specificity": "Virally suppressed HIV patients (n = 14)", "effective_dosage": "40 mg (225 \u03bcmol) once daily", "study_duration": "12 weeks of intervention, followed by a 4-week washout", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:18.841500+00:00"}
{"study_id": 38247, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining sulforaphane with amygdalin could synergistically inhibit growth and proliferation of renal cell carcinoma (RCC) cell lines.", "results_summary": "The study found that while low doses of sulforaphane or amygdalin alone had minimal effects on RCC cell growth, their combination significantly inhibited tumor cell proliferation, clone formation, and altered cell cycle regulation, with synergistic effects confirmed by the Bliss independence model.", "population_specificity": "Renal cell carcinoma (RCC) cell lines (A498, Caki-1, and KTCTL-26).", "effective_dosage": "5 \u00b5M sulforaphane.", "study_duration": "Not specified.", "interactions": "Synergistic interaction with amygdalin noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:21.389054+00:00"}
{"study_id": 38241, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore sulforaphane's neuroprotective effects and molecular mechanisms in mitigating acute carbon monoxide poisoning-induced neuronal injury in rats.", "results_summary": "Sulforaphane improved cognitive function and reduced neuronal mitochondrial damage in poisoned rats by modulating p-AMPK, MFN2, and DRP1 expression, suggesting a role in maintaining mitochondrial homeostasis.", "population_specificity": "Adult male Sprague-Dawley rats", "effective_dosage": "20 mg/kg intraperitoneal injection, once daily", "study_duration": "From 2 hours post-poisoning until euthanasia (up to 7 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:22.793796+00:00"}
{"study_id": 38249, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify molecular pathways explaining sulforaphane's potential benefits in Alzheimer's disease (AD) using advanced in silico approaches.", "results_summary": "Sulforaphane regulates 45 targets linked to neuroinflammation, insulin resistance, and apoptosis, with key pathways involving amyloid precursor protein catabolism, apoptotic signaling, and nitric oxide biosynthesis. It exhibits favorable pharmacokinetic properties, including efficient gastrointestinal absorption, blood-brain barrier penetration, and no CYP450 inhibition.", "population_specificity": "Not specified (in silico study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:23.225250+00:00"}
{"study_id": 38250, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane (SFN) could protect Cyprinus carpio haematopterus from the physiological toxicity induced by triphenyltin (TPT) and improve growth, immunity, and liver integrity.", "results_summary": "SFN supplementation improved growth performance, immunity, and antioxidant capacity while reducing oxidative stress and liver damage caused by TPT exposure in fish. It also alleviated inflammatory responses and restored liver structural integrity.", "population_specificity": "Cyprinus carpio haematopterus (a species of fish)", "effective_dosage": "10 mg kg-1 SFN in diet", "study_duration": "56 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:23.899672+00:00"}
{"study_id": 38248, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sulforaphane's potential in preventing and treating Fetal Alcohol Spectrum Disorder (FASD) by assessing its effects on ethanol-exposed zebrafish embryos.", "results_summary": "Co-treatment with 2 \u03bcM SFN and 1.5% ethanol significantly reduced ethanol-induced malformations, while post-treatment with 3 \u03bcM SFN restored body length, eye size, and other FASD features. SFN also rescued vascular development deficits caused by ethanol.", "population_specificity": "Zebrafish embryos exposed to ethanol.", "effective_dosage": "2 \u03bcM (co-treatment), 3 \u03bcM (post-treatment).", "study_duration": "Co-treatment during 3-24 hpf; post-treatment for 4 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:24.059616+00:00"}
{"study_id": 38252, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate sulforaphane's therapeutic effects on AngII-induced oxidative stress in podocytes and its mechanism via the Nrf2-Keap1/HO-1/ROS pathway.", "results_summary": "Sulforaphane alleviated AngII-induced podocyte injury by modulating the Nrf2-Keap1/HO-1/ROS pathway, reducing oxidative stress, and preventing apoptosis-related protein changes. Computational modeling showed sulforaphane binds to Nrf2, supporting its role in activating antioxidant pathways.", "population_specificity": "Mouse mpc5 podocytes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:26.892196+00:00"}
{"study_id": 38253, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the molecular effects of sulforaphane on canine intestinal epithelial cells, focusing on its potential anti-inflammatory and antioxidant properties.", "results_summary": "The study identified significant gene expression changes in inflammatory response, lipid metabolism, oxidative stress, and T-cell immunity pathways, with PPAR\u03b3 emerging as a key mediator of sulforaphane's effects.", "population_specificity": "Canine intestinal epithelial cells", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:27.291819+00:00"}
{"study_id": 38251, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify key genes involved in sulforaphane's protective effects against sepsis-associated acute kidney injury (SA-AKI) and potential intervention targets using bioinformatics and experimental validation.", "results_summary": "The study identified 17 differentially expressed genes (DEGs) linked to SA-AKI, with FKBP1A and TRRAP as potential targets of allyl isothiocyanate (a sulforaphane analog). FKBP1A mRNA expression was significantly higher in SA-AKI model tissues, suggesting sulforaphane may alleviate injury via FKBP1/NF-\u03baB targeting.", "population_specificity": "Bioinformatics analysis used human SA-AKI gene datasets; experimental validation involved rat kidney tissues.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:27.331624+00:00"}
{"study_id": 38254, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane could mitigate testicular ischemia-reperfusion injury by reducing oxidative stress and enhancing antioxidant defenses.", "results_summary": "Sulforaphane administration significantly reduced malondialdehyde content (a marker of oxidative stress) and increased superoxide dismutase and catalase protein levels, partially reversing testicular damage caused by ischemia-reperfusion.", "population_specificity": "Male rats subjected to unilateral testicular ischemia-reperfusion.", "effective_dosage": "5 mg/kg, administered intraperitoneally at detorsion.", "study_duration": "Single dose at the time of detorsion (no extended intervention period specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:30.965470+00:00"}
{"study_id": 38256, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Sulforaphane (SFN) could protect against testicular ferroptosis and toxicity induced by DEHP exposure in rats.", "results_summary": "SFN pretreatment ameliorated DEHP-induced testicular atrophy, fibrosis, reduced sperm count and motility, and oxidative stress by activating the NRF-2/SLC7A11/GPX-4 pathway, boosting antioxidant capacity, and mitigating ferroptosis.", "population_specificity": "Adult male Wistar rats", "effective_dosage": "10 mg/kg, orally (PO)", "study_duration": "1 week prior to DEHP exposure, then concurrently for 4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:31.763659+00:00"}
{"study_id": 38255, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate sulforaphane's effects on hepatic metabolism and gut microbiota in a mouse model with disrupted circadian rhythm and high-fat diet.", "results_summary": "Sulforaphane improved liver lipid accumulation, reduced intestinal inflammatory damage, modulated gut microbiota (increasing beneficial bacteria), and regulated circadian rhythm protein expression in the hypothalamus and liver.", "population_specificity": "Shifted circadian rhythm mouse model fed a high-fat diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:31.893810+00:00"}
{"study_id": 38258, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Sulforaphane (SFN) could suppress pancreatic cancer cell proliferation and induce apoptosis in PDAC cell lines.", "results_summary": "SFN inhibited cell survival and proliferation in a dose-dependent manner, induced apoptosis via ROS-mediated pathways, and activated caspase zymogens, leading to cleaved PARP and caspase-3. The ROS scavenger NAC reversed SFN-induced cytotoxicity, confirming ROS involvement in its mechanism.", "population_specificity": "Pancreatic cancer cell lines (MIA PaCa-2 and PANC-1).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:33.132279+00:00"}
{"study_id": 38257, "supplement_id": 1591, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of sulforaphane (SFN) on nerve regeneration in a murine sciatic nerve crush model, focusing on its activation of Nrf2/HO-1 pathways.", "results_summary": "SFN treatment enhanced HO-1 expression, increased repair Schwann cell proliferation, and improved functional outcomes like grip strength, nerve conduction velocity, and remyelination. The study suggests SFN modulates cytoprotective and autophagic pathways, aiding effective nerve regeneration.", "population_specificity": "C57BL/6 mice subjected to sciatic nerve crush injury.", "effective_dosage": "Daily administration (specific dosage not mentioned).", "study_duration": "Various time points post-injury (specific duration not mentioned).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:33.422740+00:00"}
{"study_id": 38259, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate Sulforaphane's potential as a multifaceted therapeutic agent for Alzheimer's disease by assessing its antioxidative, anti-inflammatory, and neuroprotective effects in a rat model.", "results_summary": "Sulforaphane improved memory deficits, reduced hippocampal A\u03b2 levels and inflammatory markers, and increased glutathione levels in a dose-dependent manner. Histopathological analyses confirmed its protective role against A\u03b2-induced neuronal damage and amyloidosis.", "population_specificity": "Rat model of Alzheimer's disease induced by A\u03b2 (1-42) peptides.", "effective_dosage": "10 mg/kg and 20 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:35.529966+00:00"}
{"study_id": 38261, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine how sulforaphane (SFN) inhibits pseudopodia formation and metastasis in bladder cancer (BC) by targeting specific molecular pathways.", "results_summary": "SFN blocked the CTTN-ARP2 axis, reducing lamellipodia collapse and invadopodia formation, inhibited ATP production essential for pseudopodia assembly, and suppressed BC metastasis in nude mice by downregulating Cttn and Arp2 expression.", "population_specificity": "Bladder cancer cells (in vitro) and nude mice (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:36.024805+00:00"}
{"study_id": 38260, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review recent research on Sulforaphane, elucidate its mechanisms of action, and discuss its potential therapeutic benefits for eye disorders.", "results_summary": "Sulforaphane demonstrated protective effects in ophthalmic diseases through multiple pathways, including antioxidative and anti-inflammatory mechanisms, and showed promise in preclinical models for conditions like diabetic retinopathy, age-related macular degeneration, cataracts, and keratoconus. Challenges remain due to its poor water solubility and limited bioavailability.", "population_specificity": "Preclinical models (murine and rabbit) and cell culture models.", "effective_dosage": "Varying concentrations (not specified) via oral delivery or intraperitoneal injection.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:38.154512+00:00"}
{"study_id": 38262, "supplement_id": 1591, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pre-clinical safety and effectiveness of sulforaphane-loaded hyaluronic acid-poloxamer hydrogel formulations for analgesic and anti-inflammatory effects.", "results_summary": "The study found that formulation F2 (PL 407/338 (18/2%) + HA 1% + SFN 0.1%) showed a longer analgesic effect, reduced inflammatory markers (TNF-\u03b1, IL-1\u03b2, and CGRP), and demonstrated biocompatibility with no significant impact on cell viability.", "population_specificity": "Wistar rats (n = 15 per group)", "effective_dosage": "10 mg/kg (intramuscular)", "study_duration": "Evaluated at 2 and 7 days post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:40.608733+00:00"}
{"study_id": 38264, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of low, dietary concentrations of sulforaphane on the proliferation and migration of triple-negative breast cancer (TNBC) cells in in vivo and in vitro models.", "results_summary": "Sulforaphane treatment resulted in up to 31% tumor growth inhibition, reduced cancer cell proliferation, decreased necrosis, altered immune cell infiltration, and fewer lung metastases. In vitro, sulforaphane inhibited cell migration but only in cells derived from 3D spheroids, not 2D cultures.", "population_specificity": "Triple-negative breast cancer (TNBC) cells and in vivo models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:40.804423+00:00"}
{"study_id": 38263, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Sulforaphane (SFN) could alleviate insulin resistance (IR) in non-alcoholic fatty liver disease (NAFLD) by regulating the gut microbiota and improving metabolic markers.", "results_summary": "SFN reduced blood glucose and insulin resistance while increasing insulin sensitivity in high-fat diet-fed rats and NAFLD patients. It reshaped gut microbiota, increased beneficial bacteria (Bacteroides, Lactobacillus, Bifidobacterium), enhanced intestinal barrier function, and activated the SCFAs-GPR41/43-GLP1 axis to improve metabolic outcomes.", "population_specificity": "HFD-fed Wistar rats and NAFLD patients with abnormal glucose levels.", "effective_dosage": "42 mg/day (broccoli seed tablets in human trial).", "study_duration": "10 weeks (rats), 12 weeks (human trial).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:42.125140+00:00"}
{"study_id": 38265, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the behavioral and biochemical effects of repeated sulforaphane treatment in an animal model of depression (olfactory bulbectomy).", "results_summary": "Sulforaphane (10 mg/kg) reversed depressive-like behaviors in the OB model and improved oxidative status by increasing total antioxidant capacity and superoxide dismutase activity in the frontal cortex and serum.", "population_specificity": "Olfactory bulbectomy (OB) animal model of depression (mice).", "effective_dosage": "10 mg/kg", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:42.283046+00:00"}
{"study_id": 38266, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the impact of Sulforaphane on oxidative stress and pyroptosis in Mycobacterium tuberculosis-infected macrophages.", "results_summary": "Sulforaphane reduced oxidative stress by activating the NRF2 signaling pathway and exhibited anti-pyroptotic effects through both NRF2-dependent and independent mechanisms, suppressing NLRP3 activation and related inflammatory markers.", "population_specificity": "Mycobacterium tuberculosis-infected RAW264.7 macrophages and primary peritoneal macrophages from WT and NRF2-/- mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:42.841929+00:00"}
{"study_id": 38267, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate sulforaphane's ability to mitigate oxidative stress, inflammation, and VEGF secretion in retinal epithelial cells treated with TGF-\u03b2.", "results_summary": "Sulforaphane reduced ROS levels, pro-inflammatory cytokines (IL-6, IL-8), and VEGF secretion while restoring epithelial integrity markers. Its effects were synergistic with vitamin D and mediated via the ERK 1/2 pathway.", "population_specificity": "ARPE-19 retinal epithelial cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:43.881597+00:00"}
{"study_id": 38268, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the molecular mechanism of sulforaphane's growth inhibition effect in acute myeloid leukemia (AML) and identify novel therapeutic targets.", "results_summary": "The study found that sulforaphane induces growth inhibition in AML cells by targeting TRIP13, and pretreatment with TRIP13 inhibitor DCZ0415 attenuated sulforaphane's effects both in vitro and in vivo. These results suggest TRIP13 plays a key role in sulforaphane's antileukemic activity.", "population_specificity": "AML cell line U937 (in vitro) and tumor models (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:44.829305+00:00"}
{"study_id": 38269, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify novel Sulforaphane-binding proteins and elucidate the mechanisms by which Sulforaphane exerts its bioactive effects.", "results_summary": "The study identified acyl protein thioesterase 2 (APT2) as a novel Sulforaphane-binding protein and found that Sulforaphane attenuates APT2 palmitoylation, reducing its plasma membrane localization. This reveals a new bioactivity of Sulforaphane as a regulator of APT2 protein palmitoylation.", "population_specificity": "Not specified (likely in vitro or animal model based on the abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:48.256810+00:00"}
{"study_id": 38271, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Sulforaphane on muscle fiber size, lipid metabolism, and related signaling pathways in mice.", "results_summary": "Sulforaphane increased muscle fiber size, reduced triglyceride and cholesterol levels, and modulated protein and lipid metabolism-related pathways, with higher doses showing more pronounced effects.", "population_specificity": "C57BL/6J mice", "effective_dosage": "1 mg/kg (SFN1) and 3 mg/kg (SFN3) daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:48.913594+00:00"}
{"study_id": 38270, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the anticancer mechanisms of Sulforaphane (SFN) and its potential as a new approach for cancer prevention and treatment.", "results_summary": "The study found that SFN exhibits significant anticancer effects through multiple mechanisms, including scavenging oxygen radicals, inducing apoptosis in tumor cells, inhibiting cell cycle progression, and suppressing tumor stem cells. These effects suggest SFN could be a promising therapeutic agent for various human cancers.", "population_specificity": "Human cancers (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:49.054475+00:00"}
{"study_id": 38274, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine Sulforaphane's regulatory effect on PD-L1 expression and its impact on checkpoint blockade therapy in gastric cancer.", "results_summary": "Sulforaphane suppressed gastric cancer cell growth in vitro and in vivo but upregulated PD-L1 expression, impairing the anticancer effect of anti-PD-L1 monoclonal antibody.", "population_specificity": "Gastric cancer cells (in vitro and in vivo study)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:50.922625+00:00"}
{"study_id": 38273, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential prophylactic mechanisms of Sulforaphane (SFN) against prefrontal cortex-related recognition memory impairment induced by lipopolysaccharide (LPS) administration in mice.", "results_summary": "SFN pretreatment significantly improved recognition memory performance, reduced neuroinflammation and oxidative stress, and mitigated neurodegeneration, A\u03b2 accumulation, and microglial hyperactivity in LPS-treated mice. The protective effects were suggested to occur via an AMPK/caspase-3-dependent pathway.", "population_specificity": "Swiss (SWR/J) mice weighing 18-25 g.", "effective_dosage": "25 mg/kg of SFN.", "study_duration": "2 weeks of treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:51.265588+00:00"}
{"study_id": 38272, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the combined effect of sulforaphane-rich broccoli sprouts (BSp) and withaferin A-rich Ashwagandha (Ash) on preventing estrogen receptor-negative mammary cancer in transgenic mice.", "results_summary": "The combination of BSp and Ash significantly reduced tumor incidence and growth (~75%), delayed tumor latency (~21%), and upregulated tumor suppressors and apoptosis-associated proteins while downregulating epigenetic machinery. RNA-seq analysis showed transcriptome-wide gene expression changes affecting cell signaling, transcription factors, and gut microbiota.", "population_specificity": "Transgenic mice with estrogen receptor-negative mammary cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:51.273483+00:00"}
{"study_id": 38275, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane could protect against LPS-induced liver injury by modulating oxidative stress, apoptosis, and metabolic markers.", "results_summary": "Sulforaphane significantly reduced liver injury markers (AST, ALT, MDA, caspase-3) and increased antioxidant activity (SOD, CAT, GSH) and AMPK levels, demonstrating protective effects against LPS-induced damage.", "population_specificity": "24 mice divided into control, LPS-induced, and SFN-treated groups.", "effective_dosage": "25 mg/kg sulforaphane.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:51.997280+00:00"}
{"study_id": 38276, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane (SFN) could inhibit NLRP3 inflammasome activation and alleviate inflammation in a mouse model of colitis.", "results_summary": "SFN administration reversed pathological changes in colitis-affected mice, significantly inhibiting NLRP3 activation, reducing inflammation, and restoring cytokine levels (IL-18 and IL-1\u03b2). It also decreased reactive oxygen species in RAW264.7 cells exposed to LPS and NLRP3 agonists.", "population_specificity": "Mice with dextran sodium sulfate-induced colitis and RAW264.7 cells.", "effective_dosage": "25 and 50 mg\u00b7kg-1\u00b7d-1, administered orally.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:54.559896+00:00"}
{"study_id": 38277, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of sulforaphane (SFN) as an NRF2 agonist on the transcriptome of bovine mammary alveolar cells, focusing on antioxidant function, cell survival, and metabolism.", "results_summary": "SFN activated NRF2 target genes, upregulated pathways linked to cell survival and antioxidant function, and suppressed genes related to cellular senescence and DNA repair. The study suggests SFN may modulate the NRF2 network but notes potential complications from effects on cellular stress and metabolism.", "population_specificity": "Immortalized bovine mammary alveolar cells (MACT)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:57.482937+00:00"}
{"study_id": 38279, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the regulatory effects of electroacupuncture combined with sulforaphane on sarcopenia, focusing on mitochondrial function and oxidative stress.", "results_summary": "Sulforaphane suppressed oxidative stress, apoptosis, and inflammatory markers (IL-6, TNF-\u03b1, Atrogin-1, MuRF1) while repairing mitochondrial damage, with enhanced effects when combined with electroacupuncture via the AMPK/Sirt1/PGC-1\u03b1 pathway.", "population_specificity": "SAMP8 mice (a model for accelerated aging and sarcopenia).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:57.684740+00:00"}
{"study_id": 38278, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how sulforaphane (SFN) affects IL-1\u03b2-induced IL-6 activation and MAPK/AP-1 signaling in HT-29 colorectal cancer cells.", "results_summary": "SFN reduced IL-1\u03b2-stimulated IL-6 expression, decreased oxidative stress by lowering ROS production, and inhibited HT-29 cell proliferation and invasiveness by modulating MAPK/AP-1 and STAT3 signaling pathways.", "population_specificity": "HT-29 colorectal cancer cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:57.827512+00:00"}
{"study_id": 38282, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the antimicrobial effects and mechanism of sulforaphane against plant pathogens and optimize its extraction for agricultural applications.", "results_summary": "The study identified genetic factors influencing sulforaphane biosynthesis, developed a protocol for high-yield extraction, and demonstrated that sulforaphane-enriched extracts effectively inhibited microbial proliferation and induced ROS accumulation in plants.", "population_specificity": "33 Brassica oleracea varieties (plant-based study).", "effective_dosage": "SFN-enriched extracts containing up to 628.44 \u03bcg/g DW of SFN.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:26:59.987165+00:00"}
{"study_id": 38281, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of sulforaphane (SFN) on right ventricular remodeling and redox homeostasis in monocrotaline-induced pulmonary arterial hypertension (PAH) in rats.", "results_summary": "SFN treatment attenuated detrimental changes in cardiac function and redox state, improving parameters like tricuspid annular plane systolic excursion, mean pulmonary artery pressure, and pulmonary vascular resistance. It also increased catalase levels and normalized the glutathione/GSSG ratio.", "population_specificity": "Male Wistar rats with monocrotaline-induced PAH.", "effective_dosage": "2.5 mg/kg/day intraperitoneally.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:00.457602+00:00"}
{"study_id": 38280, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane could prevent or treat obesity and insulin resistance in mouse models.", "results_summary": "Sulforaphane reduced fat accumulation, improved insulin sensitivity, and enhanced glucose tolerance in mice on a high-fat diet, without affecting food intake. It also increased glucose uptake and fatty acid oxidation in muscle cells.", "population_specificity": "Young and middle-aged male mice, and diet-induced-obesity (DIO) male mice.", "effective_dosage": "0.5 g/kg and 0.25 g/kg in diet (prevention), 40 mg/kg orally (treatment).", "study_duration": "20 weeks (prevention), duration not specified for treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:00.599343+00:00"}
{"study_id": 38283, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether sulforaphane (SFN) could inhibit BPDE-induced migration and invasion of lung adenocarcinoma A549 cells by upregulating NLRP12 and influencing NF-\u03baB pathways.", "results_summary": "SFN attenuated BPDE-induced migration and invasion of A549 cells, upregulated NLRP12, and reduced expression of key factors in both canonical and non-canonical NF-\u03baB pathways. NLRP12 overexpression reversed BPDE-induced effects and further suppressed NF-\u03baB pathway factors.", "population_specificity": "Human lung adenocarcinoma A549 cells", "effective_dosage": "5 \u03bcM SFN", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:00.739926+00:00"}
{"study_id": 38284, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effect of sulforaphane (SF) against oxidative stress in human keratocytes under conditions simulating keratoconus (KC).", "results_summary": "SF reduced endogenous and exogenous oxidative stress and increased cellular antioxidant capacity by activating the Nrf-2/ARE signaling pathway in human keratocytes exposed to H2O2.", "population_specificity": "Human keratocytes (HKs) cultured in vitro under conditions simulating keratoconus.", "effective_dosage": "Not specified", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:02.860603+00:00"}
{"study_id": 38285, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the pharmacological effects of Sulforaphane (SFN) on the Nrf2/ARE pathway in osteocytes, focusing on antioxidant gene expression and osteogenic markers.", "results_summary": "SFN increased antioxidant gene expression via the Nrf2/ARE pathway, enhanced osteogenic markers (osteopontin and osteocalcin), and reduced cell death under oxidative stress conditions.", "population_specificity": "MLO-Y4 murine osteocytes and a stably transduced MLO-Y4-SIN-lenti-ARE reporter gene cell line.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:06.419468+00:00"}
{"study_id": 38289, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether combining Sulforaphane (SFN) with Paclitaxel (PTX) enhances treatment efficacy in prostate cancer by promoting apoptosis and modulating cell cycle dynamics.", "results_summary": "The combination of SFN and PTX significantly reduced cell viability, increased apoptosis (via Bax/Bcl2 ratio and Caspase-3 activation), and induced S-phase arrest in prostate cancer cell lines, demonstrating synergistic effects compared to monotherapy.", "population_specificity": "Prostate cancer cell lines (PC-3 and LNCaP).", "effective_dosage": "Varying concentrations (specific amounts not detailed in abstract).", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:06.919400+00:00"}
{"study_id": 38288, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sulforaphane's influence on the adhesive and migratory properties of bladder cancer cells, including chemo-sensitive and chemo-resistant variants, and explore its mechanisms of action.", "results_summary": "Sulforaphane down-regulated adhesion and migration in bladder cancer cells by modulating integrin \u03b21 and \u03b24 expression and inducing mesenchymal-epithelial translocation of cadherins and vimentin, showing potential to improve bladder cancer therapy.", "population_specificity": "Cisplatin- and gemcitabine-sensitive and resistant bladder cancer cell lines (RT4, RT112, T24, TCCSUP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:07.286520+00:00"}
{"study_id": 38292, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review Sulforaphane's potential health benefits, focusing on its mechanisms of action in treating diseases like cancer, diabetes, obesity, and neurodegenerative disorders.", "results_summary": "Sulforaphane demonstrated anticancer effects by inhibiting tumor proliferation and inducing apoptosis, improved glucose tolerance and reduced fat accumulation (antidiabetic and anti-obesity effects), and showed antioxidant and anti-inflammatory properties beneficial for neurodegenerative diseases.", "population_specificity": "Animal models and in vitro studies.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:08.363364+00:00"}
{"study_id": 38293, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the effects of Sulforaphane on exercise-induced inflammation and oxidative stress, including its potential as a therapeutic agent in sports nutrition.", "results_summary": "The abstract highlights Sulforaphane's antioxidative and anti-inflammatory effects, supported by in vivo and in vitro studies, but notes limited human studies on its impact on exercise-induced stress. It also mentions potential synergistic effects with other nutraceuticals for inflammatory conditions.", "population_specificity": "Human and animal studies related to exercise intervention.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:08.606311+00:00"}
{"study_id": 38290, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Sulforaphane's impact on depression associated with PCOS by examining its effects on hippocampal energy sensors, cellular bioenergetics, and autophagic markers.", "results_summary": "Sulforaphane alleviated depression-like behaviors in PCOS rats by restoring autophagic function, nuclear translocation of SIRT1, and reducing inflammatory markers like FOXO1, NF-\u03baB, and TNF-\u03b1. Its antidepressant effects were counteracted by an autophagic inhibitor, confirming its mechanism of action.", "population_specificity": "Female rats with induced PCOS.", "effective_dosage": "0.5 mg/kg, intraperitoneal (i.p.) administration.", "study_duration": "One week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:09.442502+00:00"}
{"study_id": 38291, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining sulforaphane (SFN) with formononetin (FN) could inhibit cervical cancer cell proliferation by targeting the PI3K/Akt/mTOR signaling pathway in HeLa cells.", "results_summary": "The combination of FN and SFN showed significant cytotoxicity in HeLa cells with an IC50 of 21.6 \u00b5M, increased apoptotic signals, and elevated ROS generation. The treatment also suppressed PI3K, AKT, and mTOR-mediated regulation of proliferation and cell cycle proteins.", "population_specificity": "HeLa cervical cancer cells (in vitro study)", "effective_dosage": "0-50 \u00b5M (single 24-hour exposure)", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:11.102558+00:00"}
{"study_id": 38294, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effect of Sulforaphane (SFN) on macrophage polarization and its underlying regulatory mechanism, particularly its potential role in treating inflammatory bowel diseases (IBDs).", "results_summary": "SFN at an optimal concentration of 10 \u03bcM effectively shifted macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2, reduced inflammatory cytokines (IL-12, IL-6, TNF-\u03b1), and enhanced protective markers (YM1, Fizz1, Arg1). It also activated the Nrf2 pathway, which was critical for its regulatory effects, and partially alleviated LPS-induced damage to intestinal cells.", "population_specificity": "Mouse bone marrow-derived macrophages (BMDMs) and Caco-2 cells (human intestinal epithelial cell line).", "effective_dosage": "10 \u03bcM (optimal concentration identified).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:13.747704+00:00"}
{"study_id": 38295, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether sulforaphane prevents diabetes-induced hepatic ferroptosis and the mechanisms involved, focusing on Nrf2 activation.", "results_summary": "Sulforaphane reversed diabetes-induced Nrf2 inactivation, increased antiferroptotic molecules, reduced ferroptotic markers (labile iron, lipid peroxides), and improved liver damage and metabolic parameters (glucose, triglycerides).", "population_specificity": "Male C57BL/6 mice with streptozotocin-induced diabetes.", "effective_dosage": "2.5 mg/kg administered from Days 1 to 42.", "study_duration": "42 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:15.319975+00:00"}
{"study_id": 38296, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate sulforaphane's efficacy and mechanism in eliminating myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and its impact on CD8+ T-cell antitumor activity.", "results_summary": "Sulforaphane reduced MDSCs abundance, repressed tumor growth, and enhanced CD8+ T-cell activation in mice and human blood samples. It triggered MDSC apoptosis via the IL-12RB2/MMP3/FasL signaling cascade.", "population_specificity": "Mice models bearing LLC or B16 cells and human blood samples from a phase I clinical trial (KY-2021-0350).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:15.738570+00:00"}
{"study_id": 38299, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the relationship between Sulforaphane's effects on childhood autism spectrum disorders (ASD) and gut microbiota (GM) using animal models and human studies.", "results_summary": "Sulforaphane improved social behavior in ASD-like rats and communication scores in pediatric ASD patients. Gut microbiota changes were observed in both rats and humans, with some taxa correlating with symptom improvements.", "population_specificity": "Maternal immune activation (MIA)-induced ASD-like rats and pediatric autism patients.", "effective_dosage": "Not specified", "study_duration": "12 weeks for human participants", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:16.745656+00:00"}
{"study_id": 38298, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether sulforaphane (SFN) could inhibit TGF-\u03b2-induced fibrosis, inflammation, and myofibroblast differentiation in human Tenon's fibroblasts (HTFs).", "results_summary": "SFN significantly suppressed TGF-\u03b2-induced myofibroblast contraction, reduced fibronectin and \u03b1-SMA production, and lowered inflammatory markers (IL-6, IL-8, CTGF). It also attenuated TGF-\u03b2 signaling pathways (Smad2/3, ERK phosphorylation).", "population_specificity": "Human Tenon's fibroblasts (HTFs) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:17.277159+00:00"}
{"study_id": 38300, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sulforaphane's potential as a chemosensitizing agent to enhance the efficacy of conventional chemotherapy in various cancer types.", "results_summary": "Sulforaphane demonstrated potent chemosensitizing effects by modulating key cellular pathways and enhancing cancer cell sensitivity to chemotherapy, leading to synergistic inhibition of proliferation, invasion, and metastasis while promoting apoptosis. The study highlights its potential as an adjunct therapy in oncology.", "population_specificity": "Preclinical and clinical investigations across diverse cancer types (bone, brain, breast, lung, skin, etc.).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:17.896428+00:00"}
{"study_id": 38297, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how sulforaphane (SFN) affects endoplasmic reticulum (ER) stress and its role in autophagy activation and cell death.", "results_summary": "SFN induced cell-death mechanisms in a concentration- and time-dependent manner, with low concentrations promoting autophagy and higher concentrations activating cell death. SFN activated autophagy in an mTORC1-dependent manner, requiring ULK1, and pre- or co-treatment with low SFN concentrations promoted cell survival under ER stress.", "population_specificity": "Not specified (likely in vitro or cellular models based on context).", "effective_dosage": "Not specified (only relative concentrations mentioned).", "study_duration": "Not specified (only short vs. long treatment durations referenced).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:18.224077+00:00"}
{"study_id": 38301, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the stage of osteoclastogenesis targeted by SFX-01 (a stabilized form of Sulforaphane) and explore whether it exerts its effects via the NRF2 and NF-KB pathways.", "results_summary": "SFX-01 exerted inhibitory effects throughout osteoclastogenesis, with the strongest impact during the early differentiation stage. It reduced DC-STAMP levels, osteoclast nuclear number, and modified cytoskeletal architecture, with effects observed even after just 24 hours of treatment.", "population_specificity": "Bone marrow-derived osteoclasts from mice.", "effective_dosage": "Not specified.", "study_duration": "Varied (full culture duration, initial 3 days, or first 24 hours).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:20.391941+00:00"}
{"study_id": 38302, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer potential of sulforaphane analogs, particularly compound 4a, by assessing their cytotoxic effects on malignant cell lines and their mechanisms of action.", "results_summary": "Compound 4a demonstrated exceptional potency in inhibiting cancer cell proliferation, induced ROS-mediated mitochondrial dysfunction leading to apoptosis, and suppressed tumor progression in a mouse model. It interacted with IGF-R1 and blocked the PI3K-PKB/Akt pathway, reducing NRF-2 protein expression.", "population_specificity": "Malignant cell lines and 4T1-injected BALB/c syngeneic mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:23.075698+00:00"}
{"study_id": 97542, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether sulforaphane could mitigate renal fibrosis by inhibiting fibrotic pathways and enhancing antioxidant defenses.", "results_summary": "Sulforaphane showed promise in targeting renal fibrosis by inhibiting TGF-\u03b2 signaling and promoting antioxidant defenses, suggesting potential therapeutic benefits for chronic kidney disease. Further research is needed to confirm its efficacy.", "population_specificity": "Not specified (likely preclinical or animal models, given the abstract's focus on mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:23.112442+00:00"}
{"study_id": 97548, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to comprehensively review Sulforaphane's biosynthesis, metabolism, bioavailability, health benefits, and mechanisms against chronic inflammation-induced diseases and neurological disorders.", "results_summary": "Sulforaphane exhibits multiple functional benefits in alleviating chronic inflammation-induced diseases, including cancer, obesity, and type 2 diabetes, through gut microbiota-mediated hydrolysis of glucosinolates, with rapid metabolism and excretion characteristics.", "population_specificity": "Not specified (broad review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:25.007830+00:00"}
{"study_id": 97540, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the evidence on how isothiocyanates (ITCs), including sulforaphane, may inhibit AGE bioavailability to reduce RAGE-mediated oxidative and inflammatory effects.", "results_summary": "The study found that ITCs exhibit antioxidant and anti-inflammatory properties, potentially mitigating the pathogenic effects of AGEs, which are linked to chronic disease onset and progression. ITCs may disrupt AGE biogenesis, offering a novel intervention strategy for chronic disease prevention.", "population_specificity": "Not specified (general discussion of in vivo and in vitro studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:25.210913+00:00"}
{"study_id": 97546, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers sought to review the protective functions of sulforaphane in ameliorating ER stress-related diseases, including cardiovascular, central nervous system, liver, eye, and reproductive diseases, as well as diabetes, cancer, gastroenteritis, and osteoarthritis.", "results_summary": "Sulforaphane demonstrated potent antioxidant, anti-inflammatory, and anti-apoptotic properties, effectively improving various diseases by modulating ER stress pathways in both in vivo and in vitro studies. It was also noted to be well-tolerated with low toxicity.", "population_specificity": "Not specified (in vivo and in vitro studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:25.750414+00:00"}
{"study_id": 97550, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to systematically review and synthesize the protective properties of sulforaphane against toxic agents, focusing on its mechanisms of action across different organs and systems.", "results_summary": "Sulforaphane demonstrated protective effects in multiple organs, particularly the liver and nervous system, by activating the Nrf2 pathway, reducing oxidative stress, suppressing inflammation, and inhibiting apoptosis. It showed potential as a chemoprotective agent, though safe human doses require further study.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:25.954894+00:00"}
{"study_id": 97551, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the direct effects of organosulfur compounds, including Sulforaphane, on colorectal cancer mechanisms such as apoptosis, angiogenesis, and metastasis.", "results_summary": "The study found that Sulforaphane and other organosulfur compounds exhibit potential anticancer effects through multiple mechanisms, including apoptosis induction and inhibition of cancer stem cells, but emphasized the need for more in vivo studies before clinical trials.", "population_specificity": "Not specified (review of in vitro, in vivo, and clinical studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:26.625864+00:00"}
{"study_id": 97553, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Sulforaphane on Type 2 Diabetes Mellitus (T2DM) control by analyzing in vitro, in vivo, and clinical trial data.", "results_summary": "Sulforaphane demonstrated positive benefits in controlling T2DM, including activation of the PI pathway, though specific outcomes and statistical significance are not detailed in the abstract.", "population_specificity": "Not specified (includes in vitro, in vivo, and clinical trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:29.454117+00:00"}
{"study_id": 97555, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore sulforaphane's potential to reduce neuroinflammation as a treatment for hepatic encephalopathy (HE).", "results_summary": "The abstract suggests sulforaphane may help reverse HE by reducing neuroinflammation, though clinical trials are lacking. It is listed among other potential treatments targeting immune and inflammatory pathways.", "population_specificity": "Pre-clinical research (not specified if human or animal models).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:30.529911+00:00"}
{"study_id": 97554, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-cancer effects of glucosinolate metabolites, including sulforaphane, and their mechanisms of action.", "results_summary": "Sulforaphane and other isothiocyanates demonstrated potential anti-cancer effects through multiple mechanisms, such as Nrf2 induction, cytokine inhibition, apoptosis induction, and angiogenesis suppression, though some isothiocyanates may increase tumor risk.", "population_specificity": "Not specified (general focus on cancer prevention/treatment mechanisms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:30.826824+00:00"}
{"study_id": 97556, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the potential benefits of sulforaphane, a bioactive compound from broccoli sprouts, as an antioxidant, anti-inflammatory, and anti-viral agent in pregnant women with COVID-19.", "results_summary": "The abstract does not provide results, as it describes a planned pilot, double-blinded, placebo-controlled randomized trial.", "population_specificity": "Pregnant women between 20 weeks gestation, in Melbourne, Australia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:32.580837+00:00"}
{"study_id": 97559, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review preclinical findings on sulforaphane's potential benefits in ocular diseases and discuss future clinical testing.", "results_summary": "The abstract outlines preclinical evidence supporting sulforaphane's potential in treating ocular diseases like AMD, DR, glaucoma, and RP, but does not specify clinical outcomes. Future clinical testing is suggested.", "population_specificity": "Preclinical studies (not specified if human or animal models).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:33.418598+00:00"}
{"study_id": 97558, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore sulforaphane's potential as a therapeutic agent for addressing inflammation and oxidative stress in pregnancy-related pathologies like preeclampsia and severe COVID-19.", "results_summary": "The abstract suggests sulforaphane has anti-inflammatory, antioxidant, and immune-modulating properties, potentially beneficial for conditions like preeclampsia and COVID-19 due to its ability to upregulate phase-II detoxification enzymes and nuclear factor erythroid 2-related factor. However, specific clinical outcomes are not detailed.", "population_specificity": "Pregnant individuals at risk for preeclampsia or severe COVID-19 (theoretical, as this is a review).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:34.649635+00:00"}
{"study_id": 97557, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of sulforaphane (SFN) on the expression of NRF2 and NF-\u03baB in patients with chronic kidney disease undergoing hemodialysis.", "results_summary": "The study found no significant difference in NRF2 or NF-\u03baB mRNA expression after SFN supplementation, nor any effect on pro-inflammatory or oxidative stress biomarkers. SFN at 150 \u03bcmol for 2 months showed no antioxidant or anti-inflammatory effects in this population.", "population_specificity": "30 patients with chronic kidney disease on regular hemodialysis (25 completed the study).", "effective_dosage": "1 sachet/day of 2.5 g containing 1% SFN extract with 0.5% myrosinase (150 \u03bcmol SFN).", "study_duration": "2 months per intervention phase, with a 2-month washout period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:35.466325+00:00"}
{"study_id": 97561, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of oxidative stress in granulosa cell dysfunction and how sulforaphane may mitigate these effects.", "results_summary": "The study suggests that oxidative stress in granulosa cells is linked to reproductive diseases and involves multiple signaling pathways, with sulforaphane identified as a potential therapeutic agent.", "population_specificity": "Granulosa cells (in vitro or animal models, not explicitly stated).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:35.597541+00:00"}
{"study_id": 97562, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to discuss the therapeutic potential of Sulforaphane in autism spectrum disorders (ASD), focusing on its activation of the Nrf2 pathway and its neuroprotective effects.", "results_summary": "The abstract suggests Sulforaphane activates the Nrf2 pathway, which may offer neuroprotective effects against mitochondrial dysfunction, but its efficacy against ASD has not yet been evaluated.", "population_specificity": "ASD patients (theoretical, as the study appears to be a discussion rather than an empirical evaluation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:38.020199+00:00"}
{"study_id": 97567, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential neurotherapeutic role of sulforaphane in alleviating gastrointestinal and behavioral issues in ASD patients.", "results_summary": "The abstract suggests sulforaphane may act as an antioxidant, immunomodulator, gut microbiota modulator, and Nrf2 activator, potentially benefiting ASD patients, but specific results are not detailed.", "population_specificity": "Individuals with autistic spectrum disorder (ASD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:39.973081+00:00"}
{"study_id": 97563, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the transgenerational influence and epigenetic regulation of paternal sulforaphane consumption in preventing estrogen receptor-negative mammary cancer in offspring.", "results_summary": "Combined sulforaphane-rich broccoli sprouts and EGCG-rich green tea polyphenols synergistically suppressed tumor growth in offspring mice, with differential expression of tumor-related proteins and epigenetic regulation observed. Sperm analysis revealed altered gene expression and DNA methylation patterns linked to tumor suppression.", "population_specificity": "Transgenic mice (C3 and HER2/neu males and their female offspring).", "effective_dosage": "26% broccoli sprouts (w/w) in food.", "study_duration": "7 weeks before mating, with tumor monitoring for 19-25 weeks in offspring.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:40.173483+00:00"}
{"study_id": 97566, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the renoprotective effects of Sulforaphane (SFN) in preclinical models of kidney diseases through a meta-analysis and systematic review.", "results_summary": "SFN administration significantly improved creatinine clearance and reduced uremia, creatininemia, and proteinuria, demonstrating protective effects against kidney injury in preclinical models. The study also noted improvements in kidney lesion histological indices and molecular biomarkers.", "population_specificity": "Preclinical models (animal studies) of kidney diseases.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:40.447496+00:00"}
{"study_id": 97568, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review evidence on sulforaphane's potential role in treating neurovascular inflammation and BBB dysfunction related to COVID-19 and Long-COVID.", "results_summary": "The abstract suggests sulforaphane, in combination with eriodictyol and oleuropein, may be effective in mitigating neuroinflammatory responses and BBB dysfunction caused by SARS-CoV-2 spike protein.", "population_specificity": "Not specified (review of existing reports).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:42.529751+00:00"}
{"study_id": 97571, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential health benefits of Sulforaphane, particularly its role in cancer risk reduction and novel mechanisms of action.", "results_summary": "The study found that Sulforaphane modulates the tumor microenvironment, inhibits stem cell self-renewal, rearranges energy metabolism pathways, influences microbiota, and offers protective effects against cancer.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:43.140286+00:00"}
{"study_id": 97569, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review methods for enhancing glucoraphanin levels in broccoli sprouts and evaluate the immunomodulatory activities of sulforaphane.", "results_summary": "Sulforaphane, derived from glucoraphanin, was associated with reduced inflammation and potential benefits for diabetes, cardiovascular disease, and cancer risk. Inducers like physicochemical and biological elicitors were found to stimulate glucosinolate and sulforaphane biosynthesis in broccoli sprouts.", "population_specificity": "Not specified (general review, not a clinical study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:43.354846+00:00"}
{"study_id": 97570, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to examine the potential effect of Sulforaphane (SFN) on alleviating autistic behavior in children with autism spectrum disorder (ASD).", "results_summary": "The study found that mean total raw scores on the ABC and SRS-2 improved in both the SFN and placebo groups, but none of the changes reached statistical significance. Twenty-eight of the 40 randomized children completed the study.", "population_specificity": "Children aged three to seven years with autism spectrum disorder (ASD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "36 weeks (with assessments at baseline, 18 weeks, and 36 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:45.470275+00:00"}
{"study_id": 97572, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of sulforaphane and other nutraceuticals in modulating immune cell metabolism and inflammation, particularly in chronic inflammatory conditions like obesity and diabetes.", "results_summary": "The study suggests sulforaphane and other nutraceuticals can modulate immune cell metabolism and proinflammatory responses, potentially offering therapeutic benefits for obesity, metabolic syndrome, and diabetes by altering cellular energetic pathways.", "population_specificity": "Not specified (general focus on chronic inflammatory conditions like obesity and diabetes).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:47.730727+00:00"}
{"study_id": 97573, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the therapeutic effects of phytochemical ingredients, including sulforaphane, on neurodegenerative diseases by activating Nrf2 and reducing oxidative stress injury.", "results_summary": "The study found that sulforaphane, among other phytochemical ingredients, could act as an Nrf2 activator, improving antioxidant defense mechanisms and potentially combatting neurodegenerative diseases. However, further clinical trials are needed to confirm its safety and efficacy.", "population_specificity": "Preclinical studies (in vivo and in vitro) focusing on neurodegenerative diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:48.665474+00:00"}
{"study_id": 97574, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the pharmacological effects and mechanisms of sulforaphane, among other natural compounds, in treating liver fibrosis.", "results_summary": "The study highlighted sulforaphane as a sulfur-containing compound with antifibrotic effects in in-vivo and in-vitro models of liver fibrosis, suggesting its potential therapeutic benefits.", "population_specificity": "In-vivo and in-vitro models of liver fibrosis (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:49.611134+00:00"}
{"study_id": 97575, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of sulforaphane (SFN) as a TLR3 inhibitor on histamine-independent itch in mice, including acute and chronic itch models.", "results_summary": "Sulforaphane inhibited Poly I:C-induced signaling in RAW264.7 cells and suppressed PIC-evoked scratching behavior in mice. It also showed potential as an antipruritic in chronic itch models.", "population_specificity": "Mice (RAW264.7 cell line and in vivo models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:49.921723+00:00"}
{"study_id": 97576, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of sulforaphane from cruciferous vegetables in regulating inflammation and modifying gut microbial communities in the context of Inflammatory Bowel Diseases (IBD).", "results_summary": "The study highlights sulforaphane's potential in reducing inflammation and altering gut microbial communities, suggesting it may help manage IBD symptoms by promoting gut health and homeostasis.", "population_specificity": "Individuals with Inflammatory Bowel Diseases (IBD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:49.990169+00:00"}
{"study_id": 97577, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of sulforaphane on core symptoms of autism spectrum disorders in a larger randomized clinical trial.", "results_summary": "Clinician-rated scales showed significant improvement in the sulforaphane group, with one-third of participants experiencing at least a 30% decrease in symptom scores after 12 weeks, though caregiver-rated scales did not show significant changes. The effects were more pronounced in participants over 10 years old, and sulforaphane was well-tolerated.", "population_specificity": "Children and individuals with autism spectrum disorders in China (N=108).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:51.866606+00:00"}
{"study_id": 97578, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate sulforaphane's properties and benefits in cancer therapy, particularly its ability to form complexes with nanomolecules and chemotherapeutic agents to enhance antitumor responses in breast cancer cells.", "results_summary": "The study found that sulforaphane promotes key biological processes like apoptosis, cell cycle arrest, and autophagy, and suppresses signaling pathways such as PI3K/AKT/mTOR in breast cancer cells. Complexing sulforaphane with nanoparticles improved its efficacy when combined with chemotherapy drugs.", "population_specificity": "Breast cancer cells (in vitro or preclinical model, not specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:52.073635+00:00"}
{"study_id": 97579, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore how Nrf2 activation, potentially via Sulforaphane, could modulate immune responses to intracerebral haemorrhage (ICH) and improve patient outcomes.", "results_summary": "The study suggests that Nrf2 activation may enhance protective immune responses to ICH by reducing oxidative stress and harmful inflammation while promoting detoxification and antioxidant pathways. However, it does not provide direct experimental evidence for Sulforaphane's efficacy in ICH patients.", "population_specificity": "Patients with intracerebral haemorrhage (ICH) or vascular dementia, though the study is a review rather than a clinical trial.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:54.239497+00:00"}
{"study_id": 97580, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore whether quercetin, in combination with sulforaphane and other chemotherapeutic agents, could improve chemo-sensitivity in pancreatic cancer by regulating oxidative and inflammatory pathways.", "results_summary": "The study suggests that quercetin may sensitize pancreatic cancer cells to sulforaphane and other chemotherapeutic agents by modulating oxidative and inflammatory networks, potentially enhancing chemo-sensitivity. However, specific results for sulforaphane alone were not detailed.", "population_specificity": "Pancreatic cancer cells (in vitro or preclinical context, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:55.908564+00:00"}
{"study_id": 97581, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Sulforaphane as an NRF2 activator for treating Diabetic Kidney Disease (DKD) by targeting oxidative stress and inflammation.", "results_summary": "The abstract highlights that Sulforaphane and other NRF2 activators show beneficial effects in preclinical and clinical studies for DKD, though limitations like lack of larger clinical trials and delivery issues hinder clinical implementation.", "population_specificity": "Patients with Diabetic Kidney Disease (DKD) and related oxidative stress mechanisms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:56.603106+00:00"}
{"study_id": 97583, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of NRF2 activators, including Sulforaphane, to provide photoprotection against UVR-induced damage and photocarcinogenesis.", "results_summary": "The study highlights that NRF2 activation, including by Sulforaphane, upregulates cytoprotective proteins, offering comprehensive and long-lasting protection against UVR damage, particularly in photodermatosis conditions.", "population_specificity": "General skin barrier and photodermatosis conditions (no specific demographic details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:57.876298+00:00"}
{"study_id": 97582, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the anticancer, anti-metastasis, and cancer-preventive properties of sulforaphane, particularly in lung cancer, focusing on clinical and molecular pharmacological approaches.", "results_summary": "The study found that sulforaphane, along with other plant-derived compounds, can attenuate oxidative stress, suppress survival and proliferative signals, and diminish cancer stem cells (CSCs), potentially benefiting anticancer drug development and dietary recommendations for lung cancer patients.", "population_specificity": "Patients with lung cancer (particularly aggressive cancers where CSCs drive initiation, progression, and metastasis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:58.219060+00:00"}
{"study_id": 97584, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the potential role of sulforaphane, a dietary phytochemical, in preventing breast cancer by examining its binding affinity to oncogenic proteins and its chemopreventive mechanisms.", "results_summary": "Sulforaphane, among other dietary phytochemicals, showed promising outcomes as a chemopreventive agent against breast cancer development, with potential mechanisms targeting oncogenic proteins and abnormal DNA methylation.", "population_specificity": "Women at risk of sporadic breast cancer (not explicitly specified but implied by the context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:27:58.224013+00:00"}
{"study_id": 97585, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the therapeutic potential of Nrf2 activators, including Sulforaphane, in inhibiting NLRP3 inflammasome activation and its associated diseases.", "results_summary": "The study suggests that Nrf2 activators like Sulforaphane may provide therapeutic benefits by inhibiting NLRP3 inflammasome activation, reducing inflammation, and offering cytoprotective effects, though potential side effects warrant caution.", "population_specificity": "Disorders of the central nervous system and other conditions linked to NLRP3 inflammasome activation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:00.060245+00:00"}
{"study_id": 97586, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the preventative or protective effects of food-derived bioactive compounds, including sulforaphane, against health damages caused by airborne particulate matter (PM).", "results_summary": "The abstract suggests that sulforaphane and other bioactive compounds may offer protective effects against PM-induced chronic diseases, though detailed mechanisms and specific outcomes are not provided. The review highlights the potential of nutritional interventions to mitigate air pollution-related health risks.", "population_specificity": "Not specified (general review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:00.190019+00:00"}
{"study_id": 97587, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of sulforaphane, among other nutritional interventions, on immune dysfunction and inflammation in chronic kidney disease (CKD).", "results_summary": "Sulforaphane was found to slow down inflammation in CKD through mechanisms such as decreasing NF-\u03baB, NLRP3, IL-1, and IL-6, while promoting anti-inflammatory pathways like NFR2 and increasing Tregs. It may help delay CKD progression by modulating immune dysfunction.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:02.230825+00:00"}
{"study_id": 97588, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize natural compounds, including Sulforaphane, that protect vascular endothelial cells from oxidative stress via Nrf2/HO-1 signaling activation.", "results_summary": "The study found that Sulforaphane and other natural agents alleviate oxidative stress-induced apoptosis in endothelial cells, primarily through Nrf2/HO-1 pathway activation, but noted the need for further preclinical and clinical studies.", "population_specificity": "Vascular endothelial cells (in vitro or animal models implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:03.999788+00:00"}
{"study_id": 97589, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to compile information on bioactive compounds, including Sulforaphane, with established anticancer potential, their mechanisms of action, and clinical applications.", "results_summary": "The abstract highlights Sulforaphane as one of several natural bioactive compounds with anticancer potential, targeting cancer cells while sparing healthy cells, but does not provide specific results on its efficacy.", "population_specificity": "Not specified (general review of bioactive compounds).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:04.456920+00:00"}
{"study_id": 97591, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the impact of Sulforaphane on intestinal inflammation and its potential to mitigate inflammatory bowel disease (IBD).", "results_summary": "The abstract does not provide specific results regarding Sulforaphane's effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not provided.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:04.969057+00:00"}
{"study_id": 97590, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the issue of food waste in the supply chain, particularly focusing on the loss of edible plant parts during harvesting and processing.", "results_summary": "The abstract does not provide specific findings about Sulforaphane's effects, as it primarily discusses food waste and environmental concerns related to discarded plant materials.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:05.204736+00:00"}
{"study_id": 97592, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess hormetic dose responses in bone marrow stem cells (BMSCs) induced by sulforaphane, focusing on cell renewal, differentiation, and resilience to inflammatory stress.", "results_summary": "The study found that sulforaphane induces hormetic dose responses in BMSCs, similar to other stem cell types, enhancing cell proliferation, differentiation, and stress resilience. These effects suggest potential therapeutic applications for sulforaphane.", "population_specificity": "Bone marrow stem cells (BMSCs) from a broad range of animal models and humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:06.533132+00:00"}
{"study_id": 97594, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of sulforaphane and other phytochemical compounds in activating the Nrf2 pathway to mitigate toxicant-induced liver injury.", "results_summary": "Sulforaphane and other Nrf2 activators showed promising effects in resisting liver diseases by regulating cell proliferation, apoptosis, and antioxidant defense mechanisms in preclinical and in vitro studies.", "population_specificity": "Preclinical experiments and in vitro studies (no specific human population mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:08.119255+00:00"}
{"study_id": 97593, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review Sulforaphane's mechanisms of action, focusing on its anti-inflammatory, anti-oxidative, and neuroprotective effects, particularly its inhibition of NLRP3 inflammasome activation.", "results_summary": "Sulforaphane demonstrated significant anti-inflammatory and antioxidant effects by inhibiting NLRP3 inflammasome activation, reducing pro-inflammatory cytokine release, and mitigating inflammatory cell death. Both in vitro and in vivo studies supported its potential therapeutic role in various disorders.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:08.591102+00:00"}
{"study_id": 97595, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the AhR/CYP pathway in ASD development and investigate potential AhR-mediated mechanisms of drugs like sulforaphane in ASD treatment.", "results_summary": "The abstract does not provide specific results on sulforaphane's effects, only mentioning it as one of the drugs reviewed for possible AhR-mediated mechanisms in ASD treatment.", "population_specificity": "Not specified (general discussion on ASD and environmental pollutants)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:10.151294+00:00"}
{"study_id": 97596, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the role of oxidative stress in chronic kidney disease progression and potential implications of Sulforaphane.", "results_summary": "The abstract does not provide specific findings regarding Sulforaphane's effects.", "population_specificity": "Adults in the United States with chronic kidney disease.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:10.714119+00:00"}
{"study_id": 97597, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to elucidate the role of sulforaphane, among other natural substances, in bladder cancer treatment by reviewing available literature.", "results_summary": "The abstract suggests that sulforaphane modulates signaling pathways related to cell proliferation, survival, apoptosis, and cell death, based on clinical and preclinical studies. However, specific outcomes or statistical significance for sulforaphane alone are not detailed.", "population_specificity": "Preclinical and clinical studies (exact population not specified).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:12.763422+00:00"}
{"study_id": 97598, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to understand the mechanisms by which sulforaphane contributes to cancer prevention and its potential as a therapeutic agent.", "results_summary": "The study found that sulforaphane modulates carcinogen metabolism, induces cell cycle arrest, activates Nrf2, and triggers cytotoxic and apoptotic pathways, contributing to cancer prevention. Clinical studies support its potential in developing novel cancer therapies.", "population_specificity": "Not specified (general discussion of mechanisms and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:12.764865+00:00"}
{"study_id": 97599, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review Sulforaphane's pharmacological activities, drug-related issues, and approaches to improve its physicochemical and biological properties.", "results_summary": "Sulforaphane demonstrated broad-spectrum activities, including antioxidant, antitumor, anti-angiogenic, and anti-inflammatory effects, with low toxicity and good tolerability. Recent advancements in drug delivery systems aim to enhance its bioavailability and stability.", "population_specificity": "Not specified (general review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:13.184375+00:00"}
{"study_id": 97600, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to summarize current understanding of Sulforaphane's influence on ROS and ROS-related pathways and evaluate its potential role in bladder cancer treatment.", "results_summary": "The abstract suggests Sulforaphane may play a role in oxidative processes relevant to bladder cancer progression and chemoresistance, but the exact mechanism remains unclear. It reviews SFN's impact on ROS-related pathways without definitive conclusions on clinical efficacy.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:14.826936+00:00"}
{"study_id": 97601, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review Sulforaphane's chemopreventive and anticancer mechanisms in lung cancer, particularly its potential to target lung cancer stem cells.", "results_summary": "The study highlighted Sulforaphane as one of several phytochemicals with potential chemopreventive and anticancer properties in lung cancer, suggesting it may target pathways related to quiescence, inflammation, and reactive oxygen species. However, specific efficacy data or clinical outcomes for Sulforaphane were not detailed in the abstract.", "population_specificity": "Not specified (review of existing literature on lung cancer and phytochemicals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:17.270019+00:00"}
{"study_id": 97602, "supplement_id": 1591, "safety_score": "90", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the clinical effects, safety, and tolerability of Sulforaphane (SF) in children with autism spectrum disorder (ASD), as well as its impact on biomarkers related to metabolic and immunologic pathways.", "results_summary": "The study found non-statistically significant but positive trends in primary autism symptom measures (OACIS) with SF, while caregiver assessments (ABC) showed statistically significant improvements. Biomarkers related to glutathione redox status, mitochondrial respiration, and inflammation were significantly altered by SF.", "population_specificity": "Children aged 3-12 years with autism spectrum disorder (ASD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "15-week randomized phase, followed by 15-week open-label extension and 6-week no-treatment phase (total 36 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:18.963468+00:00"}
{"study_id": 97606, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of sulforaphane, among other dietary phytochemicals, in regulating miRNAs to target cancer signaling pathways.", "results_summary": "Sulforaphane was identified as one of several phytochemicals that regulate miRNAs, influencing cancer progression by modulating signaling pathways. It was noted for its potential to safely and effectively target cancer without side effects.", "population_specificity": "Not specified (general discussion of cancer patients)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:20.602311+00:00"}
{"study_id": 97607, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sulforaphane's potential in cancer prevention and therapy, focusing on its mechanisms, effects on cancer stem cells, and outcomes from human clinical trials.", "results_summary": "Sulforaphane demonstrated multiple anticancer mechanisms, including modulating carcinogen-metabolizing enzymes, inhibiting cell proliferation, inducing apoptosis, and targeting cancer stem cells. Combination therapy with conventional chemotherapy showed favorable outcomes.", "population_specificity": "Not specified (general human metabolism and clinical trials referenced).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:21.219288+00:00"}
{"study_id": 97605, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if broccoli sprout extract (BSE), a source of sulforaphane, could benefit patients with grass-induced allergic rhinitis when combined with nasal steroid spray or saline spray.", "results_summary": "The study found that Peak Nasal Inspiratory Flow (PNIF) improved significantly in groups receiving BSE combined with nasal steroid spray compared to placebo, suggesting potential benefits for allergic rhinitis symptoms. Other outcomes like Total Nasal Symptoms Scores (TNSS) and cytokine levels were not detailed in the abstract.", "population_specificity": "47 patients diagnosed with grass-induced allergic rhinitis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:21.852417+00:00"}
{"study_id": 97608, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Sulforaphane's potential in disease prevention and therapy, particularly its neuroprotective effects against Alzheimer's disease and other neurological conditions.", "results_summary": "Sulforaphane demonstrated multi-faceted neuroprotective effects, including modulation of detoxification, anti-oxidation, and immune system enzymes, and showed promise in preclinical models for Alzheimer's disease by targeting amyloid-\u03b2, tau, inflammation, oxidative stress, and neurodegeneration.", "population_specificity": "Preclinical studies (animal and cell models) and clinical trials involving various conditions (e.g., prostate cancer, breast cancer, neurological diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:23.530942+00:00"}
{"study_id": 97609, "supplement_id": 1591, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the pharmacological properties of isothiocyanates (including sulforaphane), their mechanisms of action in cancer prevention and treatment, and the potential of nanotechnology to enhance their bioavailability and efficacy.", "results_summary": "The study found that isothiocyanates, including sulforaphane, exhibit significant antioxidant, anti-inflammatory, anti-cancer, and antimicrobial activities. However, their clinical application is limited by low solubility, bioavailability, and stability, which nanotechnology may help overcome.", "population_specificity": "Not specified (general review of preclinical and clinical research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:26.411846+00:00"}
{"study_id": 97610, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review sulforaphane's health-promoting properties, particularly its effects on immune response in various diseases, with a focus on clinical trials related to immune system disorders.", "results_summary": "Sulforaphane demonstrated potential benefits in preventing cancer, improving hypertensive states, preventing type 2 diabetes-induced cardiomyopathy, protecting against gastric ulcer, aiding schizophrenia treatment, and addressing obesity. Its mechanism involves activating Nrf2 to induce antioxidant and detoxifying enzymes, with clinical trials suggesting favorable outcomes where pharmaceuticals fail.", "population_specificity": "Not specified (general review of clinical trials and immune-related disorders)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:28.239122+00:00"}
{"study_id": 97611, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effects of sulforaphane, among other phytochemicals, on Nrf2 activation in humans.", "results_summary": "The study found limited evidence that sulforaphane activates Nrf2 in humans, with mixed results across studies, many of which had poor quality or high risk of bias.", "population_specificity": "Healthy, obese, or type 2 diabetic adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:28.374857+00:00"}
{"study_id": 97604, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether chronic sulforaphane ingestion could suppress heavy resistance exercise-induced muscle damage parameters in humans.", "results_summary": "Four weeks of sulforaphane intake reduced plasma creatine kinase levels and decreased interleukin-6 levels, suggesting it suppressed muscle damage and inflammatory responses post-exercise.", "population_specificity": "Ten healthy young men (age 22.0 \u00b1 0.3 years).", "effective_dosage": "30 mg/day", "study_duration": "4 weeks per treatment phase, with a 4-week washout period between phases.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:29.126358+00:00"}
{"study_id": 97612, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining brain-training games with sulforaphane intake improves cognitive function in older adults compared to either intervention alone.", "results_summary": "Sulforaphane intake improved processing speed and working memory performance, but no additional cognitive benefits were observed when combined with brain-training games.", "population_specificity": "Older adults (144 participants, aged not specified)", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:29.545970+00:00"}
{"study_id": 97613, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of glutathione (GSH) in autism spectrum disorder (ASD) and explore its potential therapeutic targeting.", "results_summary": "The study found that imbalances in the GSH redox system contribute to ASD pathophysiology, including oxidative stress, neuroinflammation, and mitochondrial dysfunction. GSH-related mechanisms also affect glutamate excitotoxicity and epigenetic regulation.", "population_specificity": "Individuals with autism spectrum disorder (ASD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:29.897722+00:00"}
{"study_id": 97614, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of sulforaphane, focusing on its Nrf2-activating effects and implications for precision medicine in chronic kidney disease (CKD).", "results_summary": "The study highlights sulforaphane's promising potential as an Nrf2 activator, suggesting it may address oxidative stress in CKD, but does not provide specific clinical trial results or outcomes.", "population_specificity": "Chronic kidney disease (CKD) patients and animal models.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:31.406923+00:00"}
{"study_id": 97615, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the anti-cancer and epigenetic modulatory potential of sulforaphane and other isothiocyanates, focusing on their effects on molecular targets and signaling pathways.", "results_summary": "Sulforaphane demonstrated anti-proliferative, pro-apoptotic, anti-inflammatory, anti-migratory, and anti-angiogenic effects against several cancers. It also modulated key signaling pathways (PI3K, MAPK, WNT, NFkB) and epigenetic machinery (DNA methyltransferases, histone modifiers, miRNA).", "population_specificity": "Not specified (in vitro studies and clinical research referenced, but no specific human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:35.561807+00:00"}
{"study_id": 97603, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of sulforaphane in treating depression induced by cardiac interventions.", "results_summary": "Sulforaphane significantly improved depressive symptoms compared to placebo, with higher response and remission rates, and no significant difference in side effects between groups.", "population_specificity": "66 patients with a history of cardiac interventions (PCI or CABG) and mild to moderate depression.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:35.829563+00:00"}
{"study_id": 97618, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize experimental studies on Pubmed regarding the efficacy of Sulforaphane in treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and multiple sclerosis.", "results_summary": "The abstract highlights Sulforaphane's antioxidant, anti-inflammatory, and anti-apoptotic properties, suggesting its potential as a supplement to counteract neurodegenerative diseases. The review summarizes studies indicating beneficial effects, though specific outcomes are not detailed.", "population_specificity": "Neurodegenerative disease models (Alzheimer's, Parkinson's, multiple sclerosis)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:36.700191+00:00"}
{"study_id": 97622, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Sulforaphane as a multifaceted anti-inflammatory strategy for treating ARDS caused by SARS-CoV-2 by activating NRF2.", "results_summary": "The study suggests Sulforaphane may provide cytoprotection by restoring redox and protein homeostasis, promoting inflammation resolution, and facilitating repair, with preclinical evidence supporting its anti-inflammatory effects.", "population_specificity": "Not specified (preclinical models and general human applicability implied).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:37.941883+00:00"}
{"study_id": 97620, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of sulforaphane in improving cognitive function in patients with frontal brain damage.", "results_summary": "The study expects sulforaphane to yield favorable results in treating memory and learning deficits, with cognitive improvements measured via a battery of tests and changes in brain metabolites, blood markers, and gut microbiota. Secondary outcomes include improvements in functional activities, mood, and neuroimaging findings.", "population_specificity": "Patients with frontal brain damage (e.g., from brain trauma, tumors, or cerebrovascular disease).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:38.333566+00:00"}
{"study_id": 97616, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the bioavailability of sulforaphane in non-pregnant and preeclamptic women and assess its potential effects on blood pressure and endothelial function.", "results_summary": "Activated broccoli extract provided higher sulforaphane bioavailability than non-activated extract in non-pregnant women. In preeclamptic women, higher doses were needed to achieve similar levels, and sulforaphane was associated with modest blood pressure reductions and improved endothelial markers.", "population_specificity": "Non-pregnant healthy women (n=6) and women with pregnancy hypertension/preeclampsia (n=12).", "effective_dosage": "Equivalent and doubled doses of activated broccoli extract (specific amounts not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:39.021233+00:00"}
{"study_id": 97623, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sulforaphane's anti-inflammatory, antioxidant, and antimicrobial effects in THP-1-derived and PBMC-derived macrophages.", "results_summary": "Sulforaphane demonstrated anti-inflammatory and antioxidant effects, reduced M1 marker gene expression, and decreased intracellular S. aureus load but increased E. coli survival in THP-1-derived macrophages.", "population_specificity": "THP-1-derived macrophages and PBMC-derived macrophages.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:39.137814+00:00"}
{"study_id": 97624, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the role of dietary factors, particularly vegetables, in breast cancer prevention, with potential implications for Sulforaphane.", "results_summary": "The abstract does not provide specific findings about Sulforaphane's effects, only mentioning that dietary factors play a crucial role in breast cancer etiology.", "population_specificity": "Not specified (general mention of women worldwide).", "effective_dosage": "Not provided.", "study_duration": "Not provided.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:43.052214+00:00"}
{"study_id": 97625, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of Sulforaphane in improving prodromal symptoms and reducing the risk and conversion rate of psychosis in individuals at clinical high risk (CHR) for psychosis.", "results_summary": "The study is ongoing, so no results are reported yet. The abstract outlines the planned outcomes, including conversion rates of psychosis, symptom severity, neurocognitive functioning, and biomarkers of inflammation and oxidative stress.", "population_specificity": "Individuals at clinical high risk (CHR) for psychosis, identified via the Structured Interview for Prodromal Syndromes.", "effective_dosage": "Not specified in the abstract.", "study_duration": "52 weeks of intervention, with an additional 1-year follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:44.608929+00:00"}
{"study_id": 97626, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether sulforaphane, as an adjuvant to risperidone, could alleviate irritability and hyperactivity symptoms in children with autism spectrum disorder (ASD).", "results_summary": "The study found that sulforaphane significantly improved irritability and hyperactivity/noncompliance scores compared to placebo, with no significant differences in other secondary measures or adverse events.", "population_specificity": "Children aged 4-12 years with ASD.", "effective_dosage": "50 \u03bcmol/day (\u226445 kg) or 100 \u03bcmol/day (>45 kg).", "study_duration": "10 weeks.", "interactions": "Adjuvant use with risperidone.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:45.017584+00:00"}
{"study_id": 97619, "supplement_id": 1591, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate sulforaphane's hormetic dose responses and its potential biomedical and clinical relevance, particularly in disease models.", "results_summary": "Sulforaphane activated the Nrf2/ARE pathway, reducing the severity of various pathologies (e.g., neurodegenerative diseases, stroke) and enhancing stem cell proliferation, though it also increased tumor cell proliferation at low concentrations. The findings suggest broad chemoprotective potential but warrant further investigation regarding tumor cell implications.", "population_specificity": "Experimental disease models (not human subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:45.891558+00:00"}
{"study_id": 97630, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to summarize existing reports on Sulforaphane's antitumor activity, functional mechanisms, and its efficacy and toxicity in cancer treatment.", "results_summary": "Sulforaphane demonstrated promising inhibitory effects on various cancers, including breast, lung, and liver cancer, primarily by regulating biomarkers and influencing signaling pathways. The review highlighted its potential efficacy but did not provide conclusive toxicity data.", "population_specificity": "Not specified (general cancer research focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:46.863961+00:00"}
{"study_id": 97629, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of endothelial mechanoregulators in vascular health and the potential of blood flow mimetic compounds, such as Sulforaphane, to treat endothelial dysfunction and associated cardiovascular diseases.", "results_summary": "The abstract highlights the importance of endothelial mechanosensors in vascular function and suggests that pharmacological modulators, including potential compounds like Sulforaphane, may improve endothelial dysfunction and reduce atherosclerosis in experimental models.", "population_specificity": "Not specified (general discussion of endothelial cells and vascular health).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:47.314189+00:00"}
{"study_id": 97628, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize studies on sulforaphane's synergistic effects with other anticancer therapies and review its delivery strategies.", "results_summary": "Sulforaphane demonstrated activity against multiple cancer types through mechanisms like detoxification and cell cycle arrest, and it enhanced the efficacy of several anticancer agents through additive and synergistic effects. The study also highlighted the need for a comprehensive review on sulforaphane's delivery strategies.", "population_specificity": "Not specified (in vitro or in vivo studies referenced, but no specific human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effects noted with paclitaxel, docetaxel, and gemcitabine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:47.517122+00:00"}
{"study_id": 97627, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety, pharmacokinetics, and efficacy of SFX-01 (a stabilized sulforaphane composition) in patients with aneurysmal subarachnoid hemorrhage.", "results_summary": "The abstract describes the study design but does not report specific results regarding safety or efficacy outcomes, as it appears to be a protocol for an ongoing or planned trial.", "population_specificity": "Patients aged 18-80 years with aneurysmal subarachnoid hemorrhage within the previous 48 hours.", "effective_dosage": "300 mg SFX-01 twice daily.", "study_duration": "Up to 28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:47.665789+00:00"}
{"study_id": 97631, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane can interfere with cancer stem cell (CSC) pathways, potentially eliminating CSCs and improving cancer therapy outcomes.", "results_summary": "The study found that sulforaphane, along with other phytochemicals, interferes with intrinsic CSC pathways in vitro and in human xenograft mice, leading to CSC elimination. Recent clinical trials also suggest therapeutic efficacy when combined with modern cancer treatments.", "population_specificity": "Cancer stem cells (in vitro and human xenograft mice models); clinical trials in various cancer types.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:51.793798+00:00"}
{"study_id": 97632, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore sulforaphane's potential to restore normal innate immune function in chronic pulmonary diseases, particularly its ability to improve pathogen phagocytosis.", "results_summary": "The study suggests sulforaphane improves phagocytosis of pathogens in vitro, potentially reducing exacerbations and lung function decline in chronic pulmonary diseases. Other natural products and statins also show promise in modulating innate immune responses.", "population_specificity": "Not specified (in vitro study implied).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:52.538816+00:00"}
{"study_id": 97634, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of sulforaphane as a neurotherapeutic for autism spectrum disorder (ASD) by modulating gut-brain cross talk and addressing behavioral, biochemical, and mitochondrial dysfunction.", "results_summary": "The study suggests sulforaphane may help mitigate behavioral and physiological comorbidities in ASD by targeting pathways like Nrf2 and NF-\u03baB, though specific efficacy data is not detailed. The abstract highlights its potential but lacks concrete results from clinical trials.", "population_specificity": "Individuals with autism spectrum disorder (ASD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:53.218831+00:00"}
{"study_id": 97635, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the molecular pathways by which sulforaphane exerts its antitumor activity, focusing on its modulatory impact on miRNAs in various cancers.", "results_summary": "Sulforaphane demonstrated significant antitumor activity by inhibiting cancer cell proliferation, viability, migration, malignancy, and epithelial-to-mesenchymal transition, primarily through regulation of miRNAs. The study highlights sulforaphane's potential as a therapeutic agent due to its broad biological activities.", "population_specificity": "Not specified (review of existing research on various cancers)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:54.319632+00:00"}
{"study_id": 97637, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sulforaphane's potential in treating neurological disorders by activating the Nrf2 pathway.", "results_summary": "Sulforaphane demonstrated neuroprotective, antioxidative, and anti-inflammatory effects by regulating the Nrf2 pathway, making it a promising candidate for treating various neurological disorders.", "population_specificity": "Not specified (general neurological disorder context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:54.637202+00:00"}
{"study_id": 97638, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate Sulforaphane's bioavailability, clinical relevance, and potential as a nutraceutical for conditions with limited pharmaceutical solutions.", "results_summary": "Sulforaphane demonstrated high bioavailability and favorable clinical outcomes in conditions lacking satisfactory pharmaceutical treatments, with myrosinase-active broccoli sprout supplements matching clinical trial doses.", "population_specificity": "Not specified (general clinical trial populations implied)", "effective_dosage": "Not specified (doses matching clinical trials mentioned)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:54.843310+00:00"}
{"study_id": 97639, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of sulforaphane as an antineuroinflammatory therapy for autism spectrum disorder (ASD), focusing on its role in synaptic protection and behavioral improvements.", "results_summary": "The study suggests sulforaphane, along with other treatments, shows promise in improving behavioral performance in ASD, with mechanisms linked to anti-inflammation and synaptic protection. However, specific results for sulforaphane alone are not detailed in the abstract.", "population_specificity": "Individuals with autism spectrum disorder (ASD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:55.864993+00:00"}
{"study_id": 97636, "supplement_id": 1591, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether sulforaphane supplementation could increase the H. pylori eradication rate and/or reduce antibiotic-associated adverse events when combined with standard triple therapy.", "results_summary": "The study found that sulforaphane supplementation did not significantly increase H. pylori eradication rates compared to triple therapy alone and did not reduce the occurrence of adverse events. The eradication rates were similar across all groups.", "population_specificity": "Patients with H. pylori-positive chronic gastritis or peptic ulcer disease who were not resistant to clarithromycin.", "effective_dosage": "Not specified in the abstract.", "study_duration": "The intervention duration was not explicitly stated in the abstract, but eradication was assessed 4 weeks after treatment completion.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:28:55.951227+00:00"}
{"study_id": 97640, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether broccoli sprout extract (containing sulforaphane) could improve outcomes in women with early-onset preeclampsia by reducing oxidative stress and antiangiogenic factors.", "results_summary": "The study has not yet commenced, so no results are available. The abstract outlines the planned methodology and objectives but does not report findings.", "population_specificity": "Women with early-onset preeclampsia (<34 weeks gestation) at Monash Health, Melbourne, Australia.", "effective_dosage": "24 mg of activated sulforaphane, twice daily until delivery.", "study_duration": "Until delivery (duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:00.263040+00:00"}
{"study_id": 97641, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the relationships between sulforaphane formulation, bioavailability, efficacy, and dosing in preclinical and clinical studies, while addressing challenges in integrating animal and human research.", "results_summary": "The study highlights sulforaphane's chemoprotective properties and its efficacy in rodent models and over 50 clinical trials, but emphasizes the need for better dose selection, mechanistic understanding, and validated human biomarkers.", "population_specificity": "Rodent disease models and human clinical trial participants.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:00.809399+00:00"}
{"study_id": 97642, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of NRF2 agonists, including Sulforaphane, in regulating mitochondrial dysfunction in airway disorders and lung cancer.", "results_summary": "The study suggests that NRF2 agonists like Sulforaphane may enhance mitochondrial homeostasis and bioenergetics, potentially benefiting airway disorders, though clinical reports indicate mixed efficacy. In lung cancer, sustained NRF2 activation may support uncontrolled cell proliferation through metabolic reprogramming.", "population_specificity": "Airway epithelial, smooth muscle, and endothelial cells; implications for chronic obstructive lung diseases, acute lung injury, and lung cancer.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:01.841299+00:00"}
{"study_id": 97645, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sulforaphane, as an anti-inflammatory compound, could prevent behavioral abnormalities and cognitive deficits in offspring exposed to maternal immune activation (MIA).", "results_summary": "The study suggests that sulforaphane treatment during adolescence may prevent behavioral abnormalities and parvalbumin immunoreactivity deficits in the medial prefrontal cortex of adult offspring after MIA, indicating potential preventive effects for schizophrenia-related symptoms.", "population_specificity": "Juvenile rodent offspring exposed to maternal immune activation (MIA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:02.798812+00:00"}
{"study_id": 97643, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the role of epigenetic changes in breast cancer and discuss the potential of Sulforaphane as an epigenetic modulator with chemopreventive and therapeutic efficacy.", "results_summary": "The study found that Sulforaphane, among other phytochemicals, can alter epigenetic modifications in breast cancer, suggesting potential chemopreventive and therapeutic benefits. However, specific clinical outcomes or mechanistic details were not provided in the abstract.", "population_specificity": "Breast cancer (no specific patient subgroup mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:02.804317+00:00"}
{"study_id": 97644, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Sulforaphane's potential to improve bone health by increasing bone formation and reducing resorption through epigenetic regulation.", "results_summary": "Sulforaphane was shown to positively impact bone remodeling by enhancing osteoblast differentiation, reducing osteoblast apoptosis, improving bone mineralization, and decreasing osteoclast differentiation and function. It was identified as one of the few natural compounds capable of both increasing bone formation and reducing resorption.", "population_specificity": "Not specified (general bone health context, likely preclinical or clinical studies referenced in the review).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:06.948428+00:00"}
{"study_id": 97647, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore whether sulforaphane, as an antioxidant, could protect non-target tissues from oxidative damage and sensitize chemoresistant cancer cells when combined with conventional antineoplastics.", "results_summary": "The study suggests sulforaphane may control cellular reactive oxygen species levels, inhibiting oxidative damage and tumor chemoresistance mediated by NF-\u03baB or HIF-1\u03b1, potentially enhancing the efficacy of drugs like cisplatin or doxorubicin.", "population_specificity": "Preclinical (not specified if human or animal models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:08.808444+00:00"}
{"study_id": 97649, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore sulforaphane's potential to promote skeletal muscle mitochondrial biogenesis and its role in augmenting mitochondrial training adaptations.", "results_summary": "The study suggests sulforaphane may contribute to mitochondrial biogenesis in skeletal muscle, potentially aiding mitochondrial training adaptations, but does not conclusively confirm its efficacy compared to other regulatory proteins.", "population_specificity": "Not specified (likely general or clinical populations with mitochondrial deficiencies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:09.414202+00:00"}
{"study_id": 97650, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of broccoli sprout extract (BSE) supplementation on blood HDAC activity, prostate gene expression, and tissue biomarkers related to prostate cancer.", "results_summary": "The study found that BSE supplementation led to differential gene expression in prostate biopsies, including downregulation of two genes implicated in prostate cancer, and changes in blood HDAC activity and tissue biomarkers.", "population_specificity": "98 men scheduled for prostate biopsy.", "effective_dosage": "200 \u00b5mol daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:09.826549+00:00"}
{"study_id": 97648, "supplement_id": 1591, "safety_score": "65", "efficacy_score": 40, "quality_score": 60, "study_goal": "The researchers aimed to assess the feasibility, safety, and potential survival benefits of sulforaphane from broccoli sprouts in patients with pancreatic ductal adenocarcinoma undergoing palliative chemotherapy.", "results_summary": "The study found a lower mean death rate in the sulforaphane group compared to placebo during the first 6 months, but results were not statistically significant (p=0.291 at day 180). High drop-out rates and digestive side effects were noted, though the treatment did not severely impact patients' self-care abilities.", "population_specificity": "Patients with palliative chemotherapy for pancreatic ductal adenocarcinoma (29 in treatment group, 11 in placebo group).", "effective_dosage": "15 capsules daily (90 mg/508 \u03bcmol sulforaphane and 180 mg/411 \u03bcmol glucoraphanin).", "study_duration": "Up to 1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:10.894619+00:00"}
{"study_id": 97653, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical evidence on Sulforaphane's effects in chronic inflammatory diseases and explore its mechanistic insights.", "results_summary": "The study highlights Sulforaphane's antioxidant, anti-inflammatory, and chromatin-modifying properties, with potential benefits for cardiovascular disease and cancer, supported by in vitro and animal studies. Clinical evidence suggests its role in alleviating chronic inflammation.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:11.016805+00:00"}
{"study_id": 97652, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether consuming glucoraphanin-rich broccoli soup for one year alters gene expression in prostate tissue of men with localized prostate cancer, potentially reducing cancer progression risk.", "results_summary": "The study found that glucoraphanin-rich broccoli soup attenuated changes in gene expression associated with oncogenic pathways in a dose-dependent manner, suggesting a potential reduction in prostate cancer progression risk. An inverse association between cruciferous vegetable consumption and cancer progression was observed, though the study was not powered to assess clinical outcomes.", "population_specificity": "Men on active surveillance for localized prostate cancer (n=49).", "effective_dosage": "Weekly 300 mL portions of soup delivering glucoraphanin at 3x and 7x the control concentration.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:12.260588+00:00"}
{"study_id": 97654, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the molecular characteristics, mechanisms of action, and effects of sulforaphane (SFN) to assess its potential as a preventive treatment for aging and neurodegeneration.", "results_summary": "The study found that SFN activates antioxidant and anti-inflammatory responses via the Nrf2 pathway and NF-\u03baB inhibition, exhibits epigenetic effects by inhibiting HDAC and DNA methyltransferases, modifies mitochondrial dynamics, and enhances proteostasis by activating the proteasome, potentially increasing cellular lifespan and preventing neurodegeneration.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:17.090930+00:00"}
{"study_id": 97646, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the lowest effective concentration of a broccoli sprout beverage (containing sulforaphane) that enhances benzene detoxication, measured by urinary excretion of S-phenylmercapturic acid (SPMA).", "results_summary": "The high-dose broccoli sprout beverage significantly increased benzene detoxication (+63.2% SPMA excretion), while lower doses showed no significant effect. The study confirmed a dose-dependent response in sulforaphane metabolite excretion.", "population_specificity": "170 subjects in Qidong, China, randomized into placebo and three dosing groups.", "effective_dosage": "Full dose (exact amount not specified), one-half dose, and one-fifth dose, administered daily.", "study_duration": "10 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:17.409539+00:00"}
{"study_id": 97657, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the status of cancer biomarkers in CAM research, including Sulforaphane, to determine its potential as a predictive biomarker for clinical activity in cancer treatment.", "results_summary": "The study identified Sulforaphane as a promising anti-cancer natural product with potential biomarker(s) for predicting clinical activity, though further validation is needed.", "population_specificity": "Patients with cancer (specific type not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:17.650310+00:00"}
{"study_id": 97655, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of sulforaphane, among other phytochemicals, in modulating long non-coding RNAs (lncRNAs) to influence chronic diseases, particularly cancer.", "results_summary": "Sulforaphane was identified as one of the phytochemicals capable of modulating lncRNAs, potentially affecting tumor development and sensitizing cancer cells when combined with conventional drugs. The effects were primarily demonstrated in preclinical cancer models.", "population_specificity": "Preclinical studies (in vitro or animal models) focusing on cancer, rheumatoid arthritis, osteoarthritis, and nonalcoholic fatty liver disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:18.178161+00:00"}
{"study_id": 97656, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize and discuss the pharmacological effects of Sulforaphane (SFN) and its mechanisms in preventing and/or treating central nervous system (CNS) disorders.", "results_summary": "SFN demonstrated potential in preventing or treating various CNS disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy, by promoting neurogenesis and reducing oxidative stress and neuroinflammation. It also reversed cognitive and memory impairments in rodent models induced by various toxic factors.", "population_specificity": "Rodent models and general CNS disorder contexts (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:18.536709+00:00"}
{"study_id": 97658, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether long-term exposure to a sulforaphane-enriched beverage affects thyroid function and autoimmunity in humans.", "results_summary": "The study found no significant changes in thyroid function (thyroid-stimulating hormone, free thyroxine, thyroglobulin) or thyroid autoimmunity status after 84 days of sulforaphane administration, supporting its safety for chemoprevention strategies targeting Nrf2 activation.", "population_specificity": "45 female participants in a randomized clinical trial.", "effective_dosage": "Not specified in the abstract.", "study_duration": "84 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:19.841006+00:00"}
{"study_id": 97659, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the antioxidative, chemopreventive, and antitumor effects of Sulforaphane from cruciferous vegetables against prostate cancers and its molecular pathways.", "results_summary": "Sulforaphane induces apoptosis in prostate cancer cells through various mechanisms, including tumor suppressor gene transcription, oxidative response, and inhibition of antiapoptotic proteins. It also causes biochemical and epigenetic changes, preventing or reversing preneoplastic or advanced prostate lesions.", "population_specificity": "Prostate cancer cells (in vitro studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:19.850393+00:00"}
{"study_id": 97660, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to summarize the mechanisms by which Sulforaphane and other Chinese herbal compounds negatively regulate the NLRP3 inflammasome in ischemic cardio/cerebral vascular diseases (ICCVDs).", "results_summary": "Sulforaphane was found to directly inhibit NLRP3 inflammasome formation by targeting ASC or Caspase-1, potentially reducing downstream inflammatory markers like IL-18 and IL-1\u03b2 in ICCVD models. The study suggests Sulforaphane may be effective in mitigating sterile inflammatory responses in ICCVDs.", "population_specificity": "Preclinical models of ischemic cardio/cerebral vascular diseases (specific human or animal details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:21.945521+00:00"}
{"study_id": 97665, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the health benefits and properties of sulforaphane, focusing on its potential protective effects against cancer, cardiovascular disease, autism, and osteoporosis.", "results_summary": "The study highlights sulforaphane's potential benefits in reducing cancer risk, cardiovascular disease, and aiding in autism and osteoporosis, based on in vitro, in vivo, and clinical studies.", "population_specificity": "Not specified (general review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:25.414591+00:00"}
{"study_id": 97666, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify nutritional interventions, including sulforaphane, for preventing or treating mental health symptoms in schizophrenia spectrum disorders (SSD).", "results_summary": "The study found observational evidence linking sulforaphane and other phytonutrients to potential benefits in SSD, though experimental data on its efficacy were not detailed.", "population_specificity": "Patients with schizophrenia spectrum disorders (SSD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:26.739044+00:00"}
{"study_id": 97662, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the chemopreventive effects of sulforaphane and other isothiocyanates against various cancers, focusing on their molecular interactions with Nrf2 and NF-\u03baB pathways.", "results_summary": "Sulforaphane demonstrated potential anticancer properties by disrupting the Nrf2-Keap1 complex, promoting Nrf2 nuclear translocation, and modulating NF-\u03baB activity, though its NF-\u03baB inhibition was less potent than BITC. The review highlighted its broad efficacy across multiple cancer types, including breast, lung, and prostate cancers.", "population_specificity": "Not specified (in vitro and/or in vivo studies, likely preclinical models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:27.267736+00:00"}
{"study_id": 97664, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the utility of TTCA as a urinary biomarker for broccoli beverage intake, comparing glucoraphanin-rich (GRR) and sulforaphane-rich (SFR) beverages.", "results_summary": "The study found that TTCA is a common isothiocyanate-derived metabolite, significantly elevated after broccoli beverage consumption, with SFR resulting in higher excretion (\u2248176%) compared to GRR (\u224887%). TTCA was also detected in beverage powders and various cruciferous vegetables, suggesting its potential as a biomarker for crucifer intake.", "population_specificity": "50 participants in a randomized crossover clinical trial.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:27.297704+00:00"}
{"study_id": 97668, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of sulforaphane, a bioactive compound from cruciferous vegetables, in treating and preventing neurological disorders.", "results_summary": "The study highlights promising evidence from clinical and animal studies suggesting sulforaphane may be effective in addressing neurodevelopmental (e.g., autism, schizophrenia) and neurodegenerative (e.g., Alzheimer's, Parkinson's) disorders. Many ongoing studies support its potential utility.", "population_specificity": "Neurodevelopmental (autism spectrum disorder, schizophrenia) and neurodegenerative (Alzheimer's, Parkinson's) disorder patients, as well as animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:28.901524+00:00"}
{"study_id": 97667, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the chemopreventive mechanisms of sulforaphane (SFN), including its effects on drug-metabolizing enzymes, cell cycle arrest, apoptosis, and epigenetic regulation in cancer prevention.", "results_summary": "SFN demonstrated chemopreventive activity by protecting cells from carcinogens, inducing growth arrest and apoptosis in cancer cells, and modulating key signaling pathways (Nrf2-Keap1 and NF-\u03baB). It also influenced epigenetic control of genes, potentially reducing cancer initiation and progression.", "population_specificity": "Not specified (in vitro and in vivo studies referenced, but no human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:29.358620+00:00"}
{"study_id": 97670, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize current knowledge on the role of isothiocyanates (ITCs), including sulforaphane, in restoring the epigenetic landscape to counteract skin carcinogenesis.", "results_summary": "The abstract highlights that ITCs, derived from glucosinolates in cruciferous vegetables, exhibit anti-cancer properties by modulating epigenetic mechanisms, potentially reversing malignant transformations in skin cancer cells. Current evidence supports their efficacy in interacting with the epigenome to restore normal gene expression profiles.", "population_specificity": "Not specified (focus on skin cancer mechanisms in general).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:30.867632+00:00"}
{"study_id": 97671, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to identify changes in urinary metabolites associated with clinical improvements in children with ASD after sulforaphane supplementation, to explore its potential mechanism of action.", "results_summary": "Sulforaphane supplementation led to improvements in behavior and social responsiveness, with significant changes in the Social Responsiveness Scale (SRS). Urinary metabolomics revealed 77 metabolites correlated with symptom changes, linked to pathways like oxidative stress, gut microbiome, and neurotransmitter metabolism.", "population_specificity": "Children and young adults with autism spectrum disorder (ASD) and related neurodevelopmental disorders.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:34.451682+00:00"}
{"study_id": 97674, "supplement_id": 1591, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the role of sulforaphane (SF) in inhibiting breast cancer cell proliferation and inducing apoptosis, alongside other dietary phytochemicals.", "results_summary": "The study found that sulforaphane, along with ellagic acid and ursolic acid, inhibits breast cancer cell proliferation and induces apoptosis, suggesting potential benefits in breast cancer therapy. Both in vitro and in vivo effects were noted, indicating promising anticancer properties.", "population_specificity": "Women with breast cancer (in vitro and in vivo studies referenced).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:35.509281+00:00"}
{"study_id": 97672, "supplement_id": 1591, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sulforaphane-rich broccoli sprouts could ameliorate or prevent gastrointestinal disorders caused by various stressors, including H. pylori and NSAIDs.", "results_summary": "The study found that sulforaphane-rich broccoli sprouts ameliorated gastric inflammation induced by H. pylori, prevented NSAIDs-induced small intestinal injury, and improved functional constipation. However, excessive stimulation of the Nrf2-mediated antioxidant system may enhance chemoresistance and facilitate cancer cell growth.", "population_specificity": "Human gastrointestinal tract (specific population not detailed in abstract).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:35.713676+00:00"}
{"study_id": 97675, "supplement_id": 1591, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the toxicity and potential effects of oral broccoli sprout extract containing sulforaphane (BSE-SFN) at three dosages in patients with atypical nevi and a history of melanoma.", "results_summary": "The study found that oral BSE-SFN was well tolerated up to 200 \u03bcmol daily, achieved dose-dependent plasma and skin levels, reduced proinflammatory cytokines, and increased the tumor suppressor decorin. No dose-limiting toxicities were observed, and all patients completed the 28-day intervention.", "population_specificity": "Seventeen patients with at least 2 atypical nevi and a prior history of melanoma.", "effective_dosage": "50, 100, or 200 \u03bcmol daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:37.237617+00:00"}
{"study_id": 97661, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily broccoli consumption affects the absorption and metabolism of isothiocyanates derived from broccoli glucosinolates, particularly sulforaphane.", "results_summary": "The study found that daily broccoli consumption interacted with BMI to influence plasma concentrations and urinary excretion of sulforaphane metabolites, with higher BMI individuals showing different absorption patterns compared to lower BMI individuals. No significant interaction was observed with GSTM1 genotype.", "population_specificity": "18 human subjects, balanced for BMI and GSTM1 genotype.", "effective_dosage": "200 g cooked broccoli and 20 g raw daikon radish daily for 15 days, followed by 100 g broccoli and 10 g daikon radish on day 16.", "study_duration": "16 days (15 days of daily broccoli, 1 day of reduced broccoli).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:38.196127+00:00"}
{"study_id": 97676, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the interplay between WNT/\u03b2-catenin signaling and PPAR-\u03b3 in gliomas and assess sulforaphane's potential as a therapeutic agent by modulating these pathways.", "results_summary": "Sulforaphane was found to downregulate the WNT/\u03b2-catenin pathway through PPAR-\u03b3 upregulation, suggesting it may reduce tumor growth, cell proliferation, invasiveness, and angiogenesis in gliomas. The abstract highlights sulforaphane as part of a promising therapeutic approach alongside other agents.", "population_specificity": "Gliomas (specific patient demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:38.214566+00:00"}
{"study_id": 97677, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory effects of broccoli sprouts (rich in sulforaphane precursors) in overweight adults.", "results_summary": "Broccoli sprout consumption significantly reduced IL-6 and C-reactive protein levels, with anti-inflammatory effects persisting during follow-up. The study suggests sulforaphane-rich foods may help mitigate obesity-related inflammation.", "population_specificity": "40 healthy overweight adults", "effective_dosage": "30 g/day of broccoli sprouts", "study_duration": "10 weeks of intervention, 10 weeks follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:38.260370+00:00"}
{"study_id": 97678, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antimicrobial properties of isothiocyanates (ITCs), including sulforaphane, against human pathogens and their potential to replace or support common antibiotics.", "results_summary": "The abstract indicates that ITCs appear effective against important human pathogens, including resistant bacteria, but results across studies are inconsistent, making comparisons difficult. A standardized method and further research are needed.", "population_specificity": "Human pathogens (bacteria with resistant phenotypes)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:39.471390+00:00"}
{"study_id": 97679, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to validate NRF2 as a therapeutic target across multiple diseases and assess the potential of NRF2-modulating drugs, including sulforaphane, for drug development and repurposing.", "results_summary": "The study identified sulforaphane as one of several NRF2-modulating compounds with potential applications across a network of chronic diseases, including autoimmune, metabolic, and neurodegenerative conditions, supported by in silico and in vivo validation.", "population_specificity": "Not specified (broad focus on chronic diseases)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:42.784822+00:00"}
{"study_id": 97680, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical utility of sulforaphane (SFN) and phenethyl isothiocyanate (PEITC) in human disease mitigation, focusing on their potential applications in evidence-based food and nutritional policy.", "results_summary": "The study summarized clinical trials using SFN and PEITC, suggesting their potential for incorporation into larger human disease mitigation efforts, particularly when derived from their source plants. Results indicate modest but promising effects across various diseases, including cancer and autism.", "population_specificity": "Human populations in small clinical trials, with applications ranging from cancer to autism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:44.530224+00:00"}
{"study_id": 97681, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze the mechanisms by which sulforaphane modulates Nrf2, NF\u03baB, and PPAR\u03b3 signaling and evaluate its potential therapeutic effects on diabetic and cardiometabolic complications.", "results_summary": "The study found that sulforaphane activates the Nrf2 antioxidant pathway and may modulate pro-inflammatory (NF\u03baB) and metabolic (PPAR\u03b3) signaling, suggesting potential benefits for diabetic and cardiometabolic conditions. Clinical trials in Type 2 diabetic patients are ongoing to assess functional outcomes.", "population_specificity": "Type 2 diabetic patients and general cardiometabolic disorder populations (rodent and human studies discussed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:45.133094+00:00"}
{"study_id": 97682, "supplement_id": 1591, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the potential effects of sulforaphane in treating obesity and explore the valorization of Brassica co-products as a source of sulforaphane.", "results_summary": "The study found promising results for sulforaphane as a potential treatment for obesity, highlighting its potential health benefits. However, the extraction process for sulforaphane from Brassica co-products requires further improvement for economic feasibility.", "population_specificity": "Not specified (general focus on obesity-related applications).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:45.493394+00:00"}
{"study_id": 43520, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the clinical relevance of Urolithin A (UA) supplementation in preventing age-related pathologies and diseases.", "results_summary": "The review identified UA as a potential dietary intervention for slowing aging progression and preventing age-related diseases, highlighting its role in mitochondrial health and inflammation. Analysis of 15 publications supported UA's efficacy in these areas.", "population_specificity": "Not specified (general aging-related pathology focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:53.891455+00:00"}
{"study_id": 43513, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A supplementation improves echocardiographic and biochemical indices in patients with heart failure with reduced ejection fraction (HFrEF).", "results_summary": "The study found no significant effect of Urolithin A on echocardiographic measures or most biochemical markers, except for a modest increase in HDL-C levels. Other lipid indices and clinical parameters remained unchanged.", "population_specificity": "10 patients with HFrEF.", "effective_dosage": "500 mg twice daily.", "study_duration": "Two 4-week intervention periods separated by a 2-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:54.373956+00:00"}
{"study_id": 43517, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UroA) could mitigate Clostridioides difficile infection (CDI)-induced colitis by protecting gut barrier function and reducing toxin production.", "results_summary": "UroA treatment attenuated CDI-induced colon epithelial damage, reduced inflammation, preserved gut barrier integrity, and decreased toxin expression from C. difficile without killing the bacteria. The findings suggest UroA acts on both bacterial gene regulation and host responses to protect against CDI pathogenesis.", "population_specificity": "Preclinical model (mice) with CDI-induced colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:54.680252+00:00"}
{"study_id": 43516, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the molecular mechanisms of Urolithin A (UA) in alleviating acute lung injury (ALI) by targeting inflammation, oxidative stress, and apoptosis.", "results_summary": "UA reduced lung tissue damage, inflammation, oxidative stress, and apoptosis in both mice and BEAS-2B cells by targeting HMGB1 and inactivating the MAPK/NF-\u03baB signaling pathway. The study demonstrated UA's potential to treat ALI effectively.", "population_specificity": "Mice and BEAS-2B human bronchial epithelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:55.042022+00:00"}
{"study_id": 43514, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antidiabetic effects of Urolithin A (UroA) in L6 myotubes and a mouse model of type 2 diabetes (T2D).", "results_summary": "UroA increased glucose uptake in L6 myotubes via Akt and AMPK pathways, promoting GLUT4 translocation. In KK-Ay/Ta mice, UroA alleviated glucose intolerance after 3 weeks of oral administration.", "population_specificity": "L6 myotubes (in vitro) and KK-Ay/Ta mice (a model of type 2 diabetes).", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:55.323988+00:00"}
{"study_id": 43518, "supplement_id": 1643, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) enhances cGAS-STING activation and cytosolic DNA clearance, potentially offering therapeutic benefits for diseases involving aberrant cGAS-STING pathway activation.", "results_summary": "UA was found to significantly enhance cGAS-STING activation and improve cytosolic DNA clearance in human cell lines, with no obvious adverse effects reported in animal models and limited human trials. The findings suggest UA may be a promising therapeutic for diseases linked to cGAS-STING dysregulation.", "population_specificity": "Human cell lines, animal laboratory models, and limited human trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:55.392472+00:00"}
{"study_id": 43512, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanism by which Urolithin A enhances muscle strength and fatigue resistance in sleep-deprived mice via the gut-muscle axis.", "results_summary": "UA pretreatment improved motor ability, energy metabolism, and gut permeability while reducing inflammation and serum LPS levels. It also modulated gut microbiota by reducing Clostridia_UCG-014 and Candidatus_Saccharimonas while increasing Lactobacillus and Muribaculaceae.", "population_specificity": "C57BL/6 mice subjected to 48-hour sleep deprivation.", "effective_dosage": "50 mg/kg body weight.", "study_duration": "Pretreatment before 48-hour sleep deprivation (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:55.527552+00:00"}
{"study_id": 43519, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Urolithin A (UA) could mitigate cognitive impairment, neuroinflammation, and mitochondrial dysfunction induced by sleep deprivation in young and aged mice.", "results_summary": "UA pretreatment prevented neuroinflammation (reducing microglia/astrocyte activation, NF-\u03baB-NLRP3 signaling, and pro-inflammatory cytokines), improved mitochondrial function, normalized autophagy/mitophagy, preserved neuronal morphology, and prevented memory impairment in sleep-deprived mice.", "population_specificity": "Young (3-month-old) and aged (12-month-old) mice subjected to 24-hour sleep deprivation.", "effective_dosage": "2.5 mg/kg or 10 mg/kg, injected intraperitoneally daily.", "study_duration": "7 consecutive days before sleep deprivation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:29:56.094638+00:00"}
{"study_id": 43522, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers sought to determine whether Urolithin A alleviates neuropathic pain in mice by activating mitophagy.", "results_summary": "Urolithin A activated mitophagy mediated by PTEN-induced kinase 1/Parkin, promoted mitobiogenesis in neurons and microglia, and alleviated neuropathic pain in chronic constriction injury (CCI) mice.", "population_specificity": "Mice with chronic constriction injury (CCI)-induced neuropathic pain.", "effective_dosage": "Intraperitoneal injection (specific dosage not mentioned).", "study_duration": "Duration of intervention not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:02.455589+00:00"}
{"study_id": 43524, "supplement_id": 1643, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to summarize recent developments in function-promoting therapies, including Urolithin A, for improving physical functioning in older adults.", "results_summary": "The abstract does not provide specific findings about Urolithin A's effects, only mentioning it as part of a broader discussion on potential therapies.", "population_specificity": "Older adults (specifics not provided).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:30:02.616438+00:00"}
